Teleflex (TFX) 10-Q 28 Jul 16 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 26, 2016	Jul. 25, 2016
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 26, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2
Trading Symbol	TFX
Entity Registrant Name	TELEFLEX INCORPORATED
Entity Central Index Key	96,943
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		44,036,366

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Income Statement [Abstract]
Net revenues	$ 473,553	$ 452,045	$ 898,446	$ 881,475
Cost of goods sold	217,154	218,808	416,900	425,601
Gross profit	256,399	233,237	481,546	455,874
Selling, general and administrative expenses	142,983	142,228	279,331	281,925
Research and development expenses	15,472	13,443	27,825	26,327
Restructuring charges	(119)	580	9,849	5,028
Gain on sale of assets	(378)	0	(1,397)	0
Income from continuing operations before interest and taxes	98,441	76,986	165,938	142,594
Interest expense	11,907	16,207	25,691	33,379
Interest income	(129)	(154)	(209)	(323)
Loss on extinguishment of debt	19,261	10,454	19,261	10,454
Income from continuing operations before taxes	67,402	50,479	121,195	99,084
Taxes on income from continuing operations	8,007	5,280	10,620	14,612
Income from continuing operations	59,395	45,199	110,575	84,472
Operating income (loss) from discontinued operations	6	(145)	(376)	(644)
(Benefit) taxes on loss from discontinued operations	(187)	45	(257)	249
Income (loss) from discontinued operations	193	(190)	(119)	(893)
Net income	59,588	45,009	110,456	83,579
Less: Income from continuing operations attributable to noncontrolling interest	285	446	464	664
Net income attributable to common shareholders	$ 59,303	$ 44,563	$ 109,992	$ 82,915
Basic:
Income from continuing operations (in dollars per share)	$ 1.36	$ 1.08	$ 2.58	$ 2.02
Loss from discontinued operations (in dollars per share)	0	(0.01)	0	(0.02)
Net income (in dollars per share)	1.36	1.07	2.58	2
Diluted:
Income from continuing operations (in dollars per share)	1.25	0.93	2.29	1.76
Loss from discontinued operations (in dollars per share)	0.01	0	0	(0.02)
Net income (in dollars per share)	1.26	0.93	2.29	1.74
Dividends per share (in dollars per share)	$ 0.34	$ 0.34	$ 0.68	$ 0.68
Weighted average common shares outstanding
Basic (in shares)	43,549	41,560	42,598	41,514
Diluted (in shares)	47,246	48,081	48,014	47,688
Amounts attributable to common shareholders:
Income from continuing operations, net of tax	$ 59,110	$ 44,753	$ 110,111	$ 83,808
Income (loss) from discontinued operations, net of tax	193	(190)	(119)	(893)
Net income attributable to common shareholders	$ 59,303	$ 44,563	$ 109,992	$ 82,915

CONDENSED CONSOLIDATED STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Statement of Comprehensive Income [Abstract]
Net income	$ 59,588	$ 45,009	$ 110,456	$ 83,579
Other comprehensive (loss) income, net of tax:
Foreign currency translation, net of tax of $1,526, $(5,334), $(2,651) and $18,104 for the three and six month periods, respectively	(9,237)	21,203	11,218	(61,887)
Pension and other postretirement benefit plans adjustment, net of tax of $(641), $(399), $(1,270) and $(1,285) for the three and six month periods, respectively	1,246	531	2,484	2,437
Derivatives qualifying as hedges, net of tax of $984, $461, $605 and $436 for the three and six month periods, respectively	(496)	(803)	984	(759)
Other comprehensive (loss) income, net of tax:	(8,487)	20,931	14,686	(60,209)
Comprehensive income	51,101	65,940	125,142	23,370
Less: comprehensive income attributable to noncontrolling interest	239	391	397	670
Comprehensive income attributable to common shareholders	$ 50,862	$ 65,549	$ 124,745	$ 22,700

CONDENSED CONSOLIDATED STATEME4

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Statement of Comprehensive Income [Abstract]
Foreign currency translation, tax	$ 1,526	$ (5,334)	$ (2,651)	$ 18,104
Pension and other postretirement benefits plans adjustment, tax	(641)	(399)	(1,270)	(1,285)
Derivatives qualifying as hedges, tax	$ 984	$ 461	$ 605	$ 436

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Jun. 26, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 476,490	$ 338,366
Accounts receivable, net	273,530	262,416
Inventories, net	338,465	330,275
Prepaid expenses and other current assets	35,841	34,915
Prepaid taxes	30,369	30,895
Assets held for sale	7,026	6,972
Total current assets	1,161,721	1,003,839
Property, plant and equipment, net	314,665	316,123
Goodwill	1,301,348	1,295,852
Intangible assets, net	1,175,098	1,199,975
Investments in affiliates	244	152
Deferred tax assets	1,985	2,341
Other assets	45,146	53,492
Total assets	4,000,207	3,871,774
Current liabilities
Current borrowings	173,952	417,350
Accounts payable	72,787	66,305
Accrued expenses	63,396	64,017
Current portion of contingent consideration	7,453	7,291
Payroll and benefit-related liabilities	71,059	84,658
Accrued interest	5,688	7,480
Income taxes payable	12,957	8,059
Other current liabilities	16,512	8,960
Total current liabilities	423,804	664,120
Long-term borrowings	907,930	641,850
Deferred tax liabilities	317,327	315,983
Pension and postretirement benefit liabilities	143,992	149,441
Noncurrent liability for uncertain tax positions	26,415	40,400
Other liabilities	59,171	48,887
Total liabilities	1,878,639	1,860,681
Commitments and contingencies
Total common shareholders' equity	2,119,350	2,009,272
Noncontrolling interest	2,218	1,821
Total equity	2,121,568	2,011,093
Total liabilities and equity	$ 4,000,207	$ 3,871,774

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015
Cash flows from operating activities of continuing operations:
Net income	$ 110,456	$ 83,579
Adjustments to reconcile net income to net cash provided by operating activities:
Loss from discontinued operations	119	893
Depreciation expense	26,609	22,385
Amortization expense of intangible assets	31,397	29,826
Amortization expense of deferred financing costs and debt discount	6,554	8,421
Loss on extinguishment of debt	19,261	10,454
Gain on sale of assets	(1,397)	0
Changes in contingent consideration	1,242	(2,293)
Stock-based compensation	7,949	7,126
Deferred income taxes, net	(1,292)	625
Other	(1,970)	(6,301)
Changes in operating assets and liabilities, net of effects of acquisitions and disposals:
Accounts receivable	(10,237)	(17,984)
Inventories	(3,284)	(16,895)
Prepaid expenses and other current assets	238	921
Accounts payable and accrued expenses	(3,500)	(2,966)
Income taxes receivable and payable, net	(657)	(8,203)
Net cash provided by operating activities from continuing operations	181,488	109,588
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(19,535)	(31,321)
Proceeds from sale of assets	3,985	0
Payments for businesses and intangibles acquired, net of cash acquired	(3,117)	(37,559)
Investment in affiliates	0	0
Net cash used in investing activities from continuing operations	(18,667)	(68,880)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings	665,000	288,100
Reduction in borrowings	(656,479)	(250,981)
Debt extinguishment, issuance and amendment fees	(8,182)	(8,746)
Net proceeds from share based compensation plans and the related tax impacts	6,593	4,843
Payments to noncontrolling interest shareholders	0	(832)
Payments for contingent consideration	(133)	(3,989)
Dividends paid	(28,998)	(28,234)
Net cash (used in) provided by financing activities from continuing operations	(22,199)	161
Cash flows from discontinued operations:
Net cash used in operating activities	(1,183)	(1,363)
Net cash used in discontinued operations	(1,183)	(1,363)
Effect of exchange rate changes on cash and cash equivalents	(1,315)	(17,732)
Net increase in cash and cash equivalents	138,124	21,774
Cash and cash equivalents at the beginning of the period	338,366	303,236
Cash and cash equivalents at the end of the period	476,490	325,010
Non cash financing activities of continuing operations:
Settlement and exchange of convertible notes with common or treasury stock	35,197	38
Acquisition of treasury stock associated with settlement and exchange of convertible note hedge and warrant agreements	$ 85,895	$ 71

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid In Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 83,579
Other comprehensive (loss) income	(60,209)
Beginning Balance (in shares) at Dec. 31, 2015		43,517				1,908
Beginning Balance at Dec. 31, 2015	2,011,093	$ 43,517	$ 440,127	$ 2,016,176	$ (371,124)	$ (119,424)	$ 1,821
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	110,456			109,992			464
Cash dividends ($0.68 per share)	(28,998)			(28,998)
Other comprehensive (loss) income	14,686				14,753		(67)
Settlements of convertible notes (in shares)		2,168				429
Settlements of convertible notes	3,298	$ 2,168	(31,913)			$ 33,043
Settlements of note hedges associated with convertible notes (in shares)						314
Settlements of note hedges associated with convertible notes and warrants	0		85,895			$ (85,895)
Shares issued under compensation plans (in shares)		96				42
Shares issued under compensation plans	10,957	$ 96	10,264			$ 597
Deferred compensation (in shares)						(2)
Deferred compensation	76					$ 76
Ending Balance (in shares) at Jun. 26, 2016		45,781				1,749
Ending Balance at Jun. 26, 2016	$ 2,121,568	$ 45,781	$ 504,373	$ 2,097,170	$ (356,371)	$ (171,603)	$ 2,218

CONDENSED CONSOLIDATED STATEME8

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Statement of Stockholders' Equity [Abstract]
Dividends per share (in dollars per share)	$ 0.34	$ 0.34	$ 0.68	$ 0.68

Basis of presentation

Basis of presentation	6 Months Ended
	Jun. 26, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Note 1 — Basis of presentation The accompanying unaudited condensed consolidated financial statements of Teleflex Incorporated and its subsidiaries are prepared on the same basis as the annual consolidated financial statements. In the opinion of management, the financial statements reflect all adjustments, which are of a normal recurring nature, necessary for the fair statement of financial statements for interim periods in accordance with accounting principles generally accepted in the United States of America ("GAAP") and with Rule 10-01 of Securities and Exchange Commission ("SEC") Regulation S-X, which sets forth the instructions for financial statements included in Form 10-Q. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. In accordance with applicable accounting standards, the accompanying condensed consolidated financial statements do not include all of the information and footnote disclosures that are required to be included in the Company's annual consolidated financial statements. The year-end condensed consolidated balance sheet data was derived from the Company's audited financial statements, but, as permitted by Rule 10-01 of SEC Regulation S-X, does not include all disclosures required by GAAP for complete financial statements. Accordingly, the Company's quarterly condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2015 . As used in this report, the terms “we,” “us,” “our,” “Teleflex” and the “Company” mean Teleflex Incorporated and its subsidiaries, unless the context indicates otherwise. The results of operations for the periods reported are not necessarily indicative of those that may be expected for a full year.

New accounting standards

New accounting standards	6 Months Ended
	Jun. 26, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New accounting standards	Note 2 — New accounting standards In May 2014, the Financial Accounting Standards Board ("FASB"), in a joint effort with the International Accounting Standards Board ("IASB"), issued new accounting guidance to clarify the principles for recognizing revenue. The new guidance is designed to enhance the comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, and will affect any entity that enters into contracts with customers or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards. The new guidance establishes principles for reporting information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity's contracts with customers. The core principle of the new guidance is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued an amendment to the new guidance that defers the effective date. The amendment provides that the new guidance is effective prospectively for annual periods beginning after December 15, 2017 and interim periods within those years; early application is permitted for annual periods beginning after December 15, 2016. The Company is currently evaluating this guidance to determine its impact on the Company’s results of operations, cash flows and financial position. In April 2015, the FASB issued guidance for the reporting of debt issuance costs within the balance sheet. Under the new guidance, debt issuance costs related to term loans are to be presented in the balance sheet as a direct deduction from the associated debt liability, consistent with the presentation of a debt discount. Previously, debt issuance costs were presented as a deferred charge (i.e., an asset) on the balance sheet. The guidance provides uniform treatment for debt issuance costs and debt discounts and eliminates inconsistencies that previously existed with other FASB guidance. The Company retrospectively adopted this guidance as of January 1, 2016. In February 2016, the FASB issued guidance that will change the requirements for accounting for leases. The principal change under the new accounting guidance is that lessees under leases classified as operating leases will recognize a right-of-use asset and a lease liability. Current lease accounting does not require lessees to recognize assets and liabilities arising under operating leases on the balance sheet. Under the new guidance, lessees (including lessees under leases classified as finance leases and operating leases) will recognize a right-to-use asset and a lease liability on the balance sheet, initially measured as the present value of lease payments under the lease. Expense recognition and cash flow presentation guidance will be based upon whether the lease is classified as an operating lease or a finance lease (the classification criteria for distinguishing between finance leases and operating leases is substantially similar to the classification criteria for distinguishing between capital leases and operating leases under current guidance). The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition approach for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements; the guidance provides certain practical expedients. The Company is currently evaluating this guidance to determine its impact on the Company’s results of operations, cash flows and financial position. In March 2016, the FASB issued new guidance designed to simplify several aspects of the accounting for share-based payment transactions, including guidance providing generally that excess tax benefits related to share-based awards should be recorded as a reduction to income tax expense (currently, excess tax benefits generally are recorded as additional-paid-in-capital) and addressing other, related guidance on accounting for income taxes with respect to share-based payment awards; providing generally that excess tax benefits related to share-based awards should be classified along with other income tax cash flows as an operating activity (currently, excess tax benefits generally are separated from other income tax cash flows and classified as a financing activity); providing that an entity may make an accounting policy election either to base compensation cost accruals on the number of awards expected to vest (as required by current guidance) or to account for forfeitures when they occur; modifying the current exception to liability classification such that partial cash settlement of an award for tax withholding purposes would not result, by itself, in liability classification of the award if the amount withheld does not exceed the maximum statutory tax rate in the employees' applicable jurisdictions (currently, an award cannot qualify for equity classification, rather than liability classification, if the amount withheld exceeds the minimum statutory withholding requirements); and providing that cash paid by an employer when directly withholding shares for tax withholding purposes should be classified as a financing activity on the statement of cash flows (currently there is no authoritative guidance addressing this classification issue). The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted (if early adoption occurs in an interim period, any adjustments will be reflected as of the beginning of the fiscal year that includes the interim period). Depending on the particular issue addressed by the guidance, application of the guidance will be made prospectively, retrospectively or subject to a retrospective transition method. We are currently evaluating the potential impact of adopting this guidance on the Company's results of operations, cash flows and financial position. From time to time, new accounting guidance is issued by the FASB or other standard setting bodies that is adopted by the Company as of the effective date or, in some cases where early adoption is permitted, in advance of the effective date. The Company has assessed the recently issued guidance that is not yet effective and, unless otherwise indicated above, believes the new guidance will not have a material impact on the Company’s results of operations, cash flows or financial position.

Restructuring charges

Restructuring charges	6 Months Ended
	Jun. 26, 2016
Restructuring and Related Activities [Abstract]
Restructuring charges	Note 3 — Restructuring charges 2016 Manufacturing Footprint Realignment Plan On February 23, 2016, the Board of Directors of the Company approved a restructuring plan (the “2016 Plan") designed to reduce costs, improve operating efficiencies and enhance the Company’s long term competitive position. The 2016 Plan, which was developed in response to continuing cost pressures in the healthcare industry, involves the consolidation of operations and a related workforce reduction at certain of the Company’s facilities, and will primarily involve the relocation of certain manufacturing operations and relocation and outsourcing of certain distribution operations. These actions commenced in the quarter ended March 27, 2016 and are expected to be substantially completed by the end of 2018. The Company estimates that it will incur aggregate pre-tax charges in connection with the 2016 Plan of between approximately $34 million to $44 million , of which an estimated $27 million to $31 million are expected to result in future cash outlays. Most of these charges, and the related cash outlays, are expected to be made prior to the end of 2018. The following table provides a summary of the Company's current cost estimates for each major expense category associated with the 2016 Plan: Type of expense Total estimated amount expected to be incurred Employee termination benefits $14 million to $18 million Facility closure and other exit costs (1) $2 million to $3 million Accelerated depreciation charges $10 million to $13 million Other (2) $8 million to $10 million $34 million to $44 million (1) Includes costs to transfer product lines among facilities, legal, outplacement and employee relocation costs. (2) Consists of other costs directly related to the 2016 Plan, including project management and other regulatory costs. The Company recorded charges of $1.8 million during the three months ended June 26, 2016 related to the 2016 Plan consisting of accelerated depreciation and other costs, which primarily were recorded as cost of goods sold. The Company recorded $ 12.8 million during the six months ended June 26, 2016 related to the 2016 Plan, of which $10.4 million related to employee termination benefits and was recorded as restructuring expense, and $2.4 million , related to accelerated depreciation and other costs, which primarily were recorded as cost of goods sold. As the 2016 Plan progresses, management will reevaluate the estimated expenses set forth above, and may revise its estimates, as appropriate, consistent with GAAP. 2015 Restructuring Programs During 2015, the Company committed to programs associated with the reorganization of certain of its businesses and the consolidation of certain of its facilities in North America. As of June 26, 2016, the Company has incurred net aggregate restructuring charges related to the plan of $6.3 million . As of June 26, 2016 , the Company has a reserve of $0.8 million related to these programs. 2014 Manufacturing Footprint Realignment Plan In April 2014, the Board of Directors approved a restructuring plan (the “2014 Manufacturing Footprint Realignment Plan”) involving the consolidation of operations and a related reduction in workforce at certain of the Company’s facilities, and the relocation of manufacturing operations from certain higher-cost locations to existing lower-cost locations. The Company recorded charges of $2.4 million and $4.0 million for the three and six months ended June 26, 2016 , respectively, related to the 2014 Manufacturing Footprint Realignment Plan. Of this amount, $2.3 million and $4.4 million for the three and six months ended June 26, 2016 , respectively, were recorded in costs of goods sold, and related to accelerated depreciation and certain other costs. For the three month ended June 26, 2016, the charges also included $0.1 million in restructuring expense. During the six months ended June 26, 2016, the Company recorded a net reversal of restructuring expense of $0.4 million . As of June 26, 2016, the Company has incurred net aggregate restructuring charges related to the plan of $10.5 million . Additionally, as of June 26, 2016, the Company has incurred net aggregate accelerated depreciation and certain other costs in connection with the plan of $18.8 million , which were primarily included in cost of goods sold. As of June 26, 2016 , the Company has a restructuring reserve of $6.3 million in connection with the plan, all of which relates to termination benefits. For additional information on the Company's restructuring programs, see Note 4 to the Company's consolidated financial statements included in its annual report on Form 10-K for the year ended December 31, 2015. The restructuring charges recognized for the three and six months ended June 26, 2016 and June 28, 2015 consisted of the following: Three Months Ended June 26, 2016 (in thousands) Termination Benefits Facility Closure Costs Contract Termination Costs Other Exit Costs Total 2016 Manufacturing footprint realignment plan $ (279 ) $ — $ — $ 286 $ 7 2015 Restructuring programs (442 ) 55 115 25 (247 ) 2014 Manufacturing footprint realignment plan 112 — — 9 121 Total restructuring charges $ (609 ) $ 55 $ 115 $ 320 $ (119 ) Three Months Ended June 28, 2015 (in thousands) Termination Benefits Facility Contract Termination Costs Other Exit Costs Total 2015 Restructuring programs $ 9 $ 63 $ 24 $ 46 $ 142 2014 Manufacturing footprint realignment plan 75 204 228 — 507 Other restructuring programs - prior years (1) (96 ) — 9 18 (69 ) Total restructuring charges $ (12 ) $ 267 $ 261 $ 64 $ 580 Six Months Ended June 26, 2016 (in thousands) Termination Benefits Facility Contract Termination Costs Other Exit Costs Total 2016 Manufacturing footprint realignment plan $ 10,068 $ — $ — $ 286 $ 10,354 2015 Restructuring programs (399 ) 178 93 118 (10 ) 2014 Manufacturing footprint realignment plan (426 ) — — 11 (415 ) Other restructuring programs - prior years (1) — — (86 ) 6 (80 ) Total restructuring charges $ 9,243 $ 178 $ 7 $ 421 $ 9,849 Six Months Ended June 28, 2015 (in thousands) Termination Benefits Facility Closure Costs Contract Termination Costs Other Exit Costs Total 2015 Restructuring programs $ 3,559 $ 129 $ 645 $ 47 $ 4,380 2014 Manufacturing footprint realignment 212 230 228 — 670 Other restructuring programs - prior years (1) (85 ) — 28 35 (22 ) Total restructuring charges $ 3,686 $ 359 $ 901 82 $ 5,028 (1) Other restructuring programs - prior years includes the 2014 European Restructuring Plan, the Other 2014 restructuring programs, the 2013 Restructuring programs and the LMA restructuring program. For a description of these plans, see Note 4 to the Company’s consolidated financial statements included in its annual report on Form 10-K for the year ended December 31, 2015. Termination benefits include estimated employee retention, severance and benefit payments for terminated employees. Facility closure costs include general operating costs incurred subsequent to production shutdown as well as legal costs, equipment relocation and other associated costs. Contract termination costs include costs associated with terminating existing leases and distributor agreements. Other costs include outplacement and employee relocation costs and other employee-related costs. Restructuring charges by reportable operating segment for the three and six months ended June 26, 2016 and June 28, 2015 are set forth in the following table: Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) (Dollars in thousands) Restructuring charges Vascular North America $ 351 $ 520 $ 4,514 $ 2,783 Anesthesia North America 364 (2 ) 2,239 534 Surgical North America — — (20 ) 246 EMEA (949 ) (43 ) 2,923 (75 ) Asia (2 ) 1 — 1 OEM (1 ) — 4 — All other 118 104 189 1,539 Total restructuring charges $ (119 ) $ 580 $ 9,849 $ 5,028

Inventories, net

Inventories, net	6 Months Ended
	Jun. 26, 2016
Inventory Disclosure [Abstract]
Inventories, net	Note 4 — Inventories, net Inventories as of June 26, 2016 and December 31, 2015 consisted of the following: June 26, 2016 December 31, 2015 (Dollars in thousands) Raw materials $ 79,199 $ 76,037 Work-in-process 57,129 60,218 Finished goods 239,161 230,536 375,489 366,791 Less: inventory reserve (37,024 ) (36,516 ) Inventories, net $ 338,465 $ 330,275

Goodwill and other intangible a

Goodwill and other intangible assets, net	6 Months Ended
	Jun. 26, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and other intangible assets, net	Note 5 — Goodwill and other intangible assets, net The following table provides information relating to changes in the carrying amount of goodwill by reportable segment for the six months ended June 26, 2016 : Vascular Anesthesia Surgical EMEA Asia OEM All Total (Dollars in thousands) Balance as of December 31, 2015 $ 345,546 $ 141,122 $ 250,912 $ 306,009 $ 141,067 $ 1,194 $ 110,002 $ 1,295,852 Currency translation adjustment — 405 — 367 6,864 — (2,140 ) 5,496 Balance as of June 26, 2016 $ 345,546 $ 141,527 $ 250,912 $ 306,376 $ 147,931 $ 1,194 $ 107,862 $ 1,301,348 The following table provides information as of June 26, 2016 and December 31, 2015 regarding the gross carrying amount of, and accumulated amortization relating to, intangible assets, net: Gross Carrying Amount Accumulated Amortization June 26, 2016 December 31, 2015 June 26, 2016 December 31, 2015 (Dollars in thousands) Customer relationships $ 624,851 $ 621,078 $ (228,493 ) $ (214,924 ) In-process research and development 58,614 58,908 — — Intellectual property 523,189 522,374 (189,454 ) (173,903 ) Distribution rights 23,340 23,279 (15,005 ) (14,393 ) Trade names 387,388 384,821 (11,466 ) (8,929 ) Non-compete agreements 2,846 2,186 (712 ) (522 ) $ 1,620,228 $ 1,612,646 $ (445,130 ) $ (412,671 ) In May 2012, the Company acquired Semprus BioSciences Corp. ("Semprus"), a biomedical research and development company that developed a polymer surface treatment technology intended to reduce thrombus related complications. As previously disclosed, the Company experienced difficulties with respect to the development of the Semprus technology, and devoted further research and testing towards attempting to resolve the issue. As a result of these efforts, the Company believes it has resolved the issue and is focused on seeking regulatory approval and engaging in additional research and development efforts to achieve commercialization of the technology. Despite the progress made since these issues were first identified, significant challenges to commercialization of the Semprus technology remain, and the Company ultimately may find it necessary to recognize impairment charges with respect to the related assets, which could be material. As of June 26, 2016 , the Company has in-process research and development intangible assets of $41.0 million related to this investment, which is recorded in intangible assets, net. Amortization expense related to intangible assets was $16.0 million and $15.1 million for the three months ended June 26, 2016 and June 28, 2015 , respectively, and $31.4 million and $29.8 million for the six months ended June 26, 2016 and June 28, 2015 , respectively.

Borrowings

Borrowings	6 Months Ended
	Jun. 26, 2016
Debt Disclosure [Abstract]
Borrowings	Note 6 — Borrowings The Company's borrowings at June 26, 2016 and December 31, 2015 are as follows: June 26, 2016 December 31, 2015 (Dollars in thousands) Senior Credit Facility: Revolving credit facility, at a rate of 1.95% at June 26, 2016, due 2018 $ 268,000 $ 396,000 3.875% Convertible Senior Subordinated Notes due 2017 136,162 399,641 4.875% Senior Notes due 2026 400,000 — 5.25% Senior Notes due 2024 250,000 250,000 Securitization program, at a rate of 1.20% at June 26, 2016 43,300 43,300 1,097,462 1,088,941 Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes due 2017 (4,956 ) (22,999 ) Less: Unamortized debt issuance costs (10,624 ) (6,742 ) 1,081,882 1,059,200 Current borrowings (173,952 ) (417,350 ) Long-term borrowings $ 907,930 $ 641,850 4.875% Senior Notes On May 16, 2016, the Company issued $400.0 million of 4.875% Senior Notes due 2026 (the "2026 Notes"). The Company will pay interest on the 2026 Notes semi-annually on June 1 and December 1, commencing on December 1, 2016, at a rate of 4.875% per year. The 2026 Notes mature on June 1, 2026 unless earlier redeemed by the Company at its option, as described below, or purchased by the Company at the holder’s option under specified circumstances following a Change of Control or Asset Sale (each as defined in the Indenture related to the 2026 Notes) or upon the Company’s election to exercise its optional redemption rights, as described below. The Company incurred transaction fees of approximately $6.2 million , including underwriters’ discounts and commissions in connection with the offering of the 2026 Notes, which were recorded as a reduction to long-term borrowings and are being amortized over the term of the 2026 Notes. The Company used the net proceeds from the offering to repay borrowings under the Company’s revolving credit facility. The Company's obligations under the 2026 Notes are fully and unconditionally guaranteed, jointly and severally, by each of the Company’s existing and future 100% owned domestic subsidiaries that is a guarantor or other obligor under the Company’s revolving credit facility and by certain of the Company’s other 100% owned domestic subsidiaries. At any time on or after June 1, 2021, the Company may, on one or more occasions, redeem some or all of the 2026 Notes at a redemption price of 102.438% of the principal amount of the 2026 Notes subject to redemption, declining, in annual increments of 0.813% , to 100% of the principal amount on June 1, 2024, plus accrued and unpaid interest. In addition, at any time prior to June 1, 2021, the Company may, on one or more occasions, redeem some or all of the 2026 Notes at a redemption price equal to 100% of the principal amount of the 2026 Notes redeemed, plus a “make-whole” premium and any accrued and unpaid interest. The “make-whole” premium is the greater of (a) 1.0% of the principal amount of the 2026 Notes subject to redemption or (b) the excess, if any, over the principal amount of the 2026 Notes of the present value, on the redemption date of the sum of (i) the June 1, 2021 optional redemption price plus (ii) all required interest payments on the 2026 Notes through June 1, 2021 (other than accrued and unpaid interest to the redemption date), generally computed using a discount rate equal to the yield to maturity of U.S. Treasury securities with a constant maturity for the period most nearly equal to the period from the redemption date to June 1, 2021, plus 50 basis points. In addition, at any time prior to June 1, 2019, the Company may, on one or more occasions, redeem up to 40% of the aggregate principal amount of the 2026 Notes, using the proceeds of specified types of Company equity offerings and subject to specified conditions, at a redemption price equal to 104.875% of the principal amount of the Notes redeemed, plus accrued and unpaid interest. The 2026 Notes contain covenants that, among other things, limit or restrict the Company’s ability, and the ability of its subsidiaries, to incur additional debt, or issue preferred stock or other disqualified stock; create liens; pay dividends, make investments or make other restricted payments; sell assets; merge, consolidate, sell or otherwise disposes of all or substantially all of the Company's assets; or enter into transactions with the Company's affiliates. 3.875% Convertible Senior Subordinated Notes For a discussion regarding the classification of the Convertible Notes as a current liability, see Note 8 to the Company's consolidated financial statements included in its annual report on Form 10-K for the year ended December 31, 2015. Exchange Transactions On April 4, 2016, pursuant to separate, privately negotiated agreements between the Company and certain of the holders (the "Holders") of its 3.875% Convertible Senior Subordinated Notes due 2017 (the "Convertible Notes"), the Company paid cash and common stock (the "Exchange Consideration") to the Holders in exchange for $219.2 million aggregate principal amount of the Convertible Notes (the "Exchange Transactions"). The Exchange Consideration paid to the Holders per $1,000 principal amount of Convertible Notes is equal to: (i) $1,000 in cash, (ii) a number of shares of the Company’s common stock equal to the amount of the conversion value of the Convertible Notes in excess of the $1,000 principal amount (the "Conversion Shares"), calculated on the basis of the average daily volume weighted average price (the "Average Daily VWAP") per share of Company common stock over a specified period , (iii) an inducement payment in additional shares of common stock (the "Inducement Shares"), calculated based on the Average Daily VWAP and (iv) cash in an amount equal to accrued and unpaid interest to, but not including, the closing date. As a result of the Exchange Transactions, the Company paid the Holders aggregate cash consideration of $220.7 million (which includes $1.5 million in accrued but previously unpaid interest) and issued and delivered to the Holders 2.17 million shares of Company common stock (including both Conversion Shares and Inducement Shares).The Company funded the $220.7 million cash payment constituting part of the Exchange Consideration through borrowings under its revolving credit agreement. The issuance of the shares of the Company’s common stock to the Holders pursuant to the Exchange Transactions was made pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), under Section 3(a)(9) of the Securities Act. As a result of the Exchange Transactions, the Company recognized a loss on extinguishment of debt of $16.3 million . In connection with entering into the Exchange Transactions, the Company also entered into bond hedge unwind agreements (the "Hedge Unwind Agreements") with the dealer counterparties to the convertible note hedge transactions related to the Convertible Notes. Under the Hedge Unwind Agreements, the number of call options subject to the Convertible Note hedge transactions was reduced to reflect proportionately the reduction in the outstanding principal amount of the Convertible Notes following the Exchange Transactions. In addition, the Company entered into warrant unwind agreements (the “Warrant Unwind Agreements”) with the dealer counterparties to reduce the number of warrants initially issued to the dealer counterparties, also in connection with the initial issuance of the Convertible Notes. On a net basis, after giving effect to the Hedge Unwind Agreements and Warrant Unwind Agreements, the Company received 0.3 million shares of Company common stock from such dealer counterparties. Conversions During the second quarter of 2016, the Company made settlement with respect to conversion notices previously received by the Company in respect of $44.3 million in aggregate principal amount of the Convertible Notes (the "Converted Notes"). In accordance with the terms of the supplemental indenture relating to the Convertible Notes, the Company elected to deliver to the holders of the Converted Notes (the "Converting Holders") a combination of cash and shares of Company common stock, based on the conversion methodology set forth in the supplemental indenture. The Company provided the Converting Holders, in the aggregate, $44.3 million in cash and 0.4 million shares of Company common stock. As a result of the conversions, the Company recognized a loss on extinguishment of debt of $3.0 million . Under the terms of the agreements related to the Convertible Note hedge transactions, and in connection with the conversions described above, the counterparties to the Convertible Note hedge transactions delivered to the Company a number of shares of Company common stock equal to the number of shares of Company common stock delivered to the Converting Holders. Additionally, the Company entered into warrant unwind agreements with the dealer counterparties to reduce the number of warrants initially issued. The Company received 0.4 million shares of Company common stock to the dealer counterparties in connection with the warrant unwind agreements. Repayment of Revolving Credit Facility Borrowings In July 2016, we repaid $50.0 million of borrowings under the revolving credit agreement using available cash. Fair Value of Long-Term Borrowings To determine the fair value of the debt categorized as Level 2 in the table below, the Company uses a discounted cash flow technique that incorporates a market interest yield curve with adjustments for duration, optionality and risk profile. The Company’s implied credit rating is a factor in determining the market interest yield curve. The following table provides the fair value of the Company’s debt as of June 26, 2016 and December 31, 2015, categorized by the level of inputs within the fair value hierarchy used to measure fair value (see Note 10, “Fair value measurement,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 for further information): June 26, 2016 December 31, 2015 (Dollars in thousands) Level 1 $ 389,423 $ 858,709 Level 2 987,010 687,072 Total $ 1,376,433 $ 1,545,781

Financial instruments

Financial instruments	6 Months Ended
	Jun. 26, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial instruments	Note 7 — Financial instruments Foreign Currency Forward Contracts Designated as Cash Flow Hedges The Company uses derivative instruments for risk management purposes. Foreign currency forward contracts are used to manage foreign currency transaction exposure. These derivative instruments are designated as cash flow hedges and are recorded on the condensed consolidated balance sheet at fair market value. The effective portion of the gains or losses on derivatives is reported as a component of other comprehensive loss and thereafter is recognized in the condensed consolidated statement of income in the period or periods during which the hedged transaction affects earnings. Gains and losses on the derivatives representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, if any, are recognized in the condensed consolidated statement of income in the period in which such gains and losses occur. Non-designated Foreign Currency Forward Contracts During the third quarter 2015, the Company began using foreign currency forward contracts as a part of its strategy to manage exposure related to near term foreign currency denominated monetary assets and liabilities. These currency forward contracts are not designated as cash flow, fair value or net investment hedges; therefore, the changes in fair value are recorded in the condensed consolidated statement of income as a selling, general and administrative expense. The Company enters into foreign currency forward contracts for periods consistent with currency transaction exposures, approximately one month. For the three and six months ended June 26, 2016 , the Company recognized a loss related to non-designated foreign currency forward contracts of $1.3 million and $1.6 million , respectively. The following table presents the location and fair value of derivative financial instruments reported in the condensed consolidated balance sheet as of June 26, 2016 and December 31, 2015 : June 26, 2016 December 31, 2015 Fair Value Fair Value (Dollars in thousands) Asset derivatives: Designated foreign currency forward contracts $ 1,211 $ 285 Non-designated foreign currency forward contracts 455 44 Prepaid expenses and other current assets $ 1,666 $ 329 Total asset derivatives $ 1,666 $ 329 Liability derivatives: Designated foreign currency forward contracts $ 3,366 $ 807 Non-designated foreign currency forward contracts 1,406 491 Other current liabilities $ 4,772 $ 1,298 Total liability derivatives $ 4,772 $ 1,298 The total notional amount for all open foreign currency forward contracts designated as cash flow hedges as of June 26, 2016 and December 31, 2015 was $162.9 million and $49.5 million , respectively. The total notional amount for all open non-designated foreign currency forward contracts as of June 26, 2016 and December 31, 2015 was $75.6 million and $69.1 million , respectively. All open foreign currency forward contracts as of June 26, 2016 have durations of nine months or less. The following table provides information as to the gains and losses attributable to derivatives in cash flow hedging relationships that were reported in other comprehensive income (loss) (“OCI”) for the three and six months ended June 26, 2016 and June 28, 2015 : After Tax Gain (Loss) Recognized in OCI Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) Foreign currency forward contracts $ (496 ) $ (803 ) $ 984 $ (759 ) Total $ (496 ) $ (803 ) $ 984 $ (759 ) See Note 9 for information on the location in the condensed consolidated statements of income and amount of losses/(gains) attributable to derivatives that were reclassified from accumulated other comprehensive loss (“AOCL”) to expense (income), net of tax. There was no ineffectiveness related to the Company’s hedging derivatives during the three and six months ended June 26, 2016 and June 28, 2015 . Concentration of Credit Risk Concentrations of credit risk with respect to trade accounts receivable are generally limited due to the Company’s large number of customers and their diversity across many geographic areas. A portion of the Company’s trade accounts receivable outside the United States, however, include sales to government-owned or supported healthcare systems in several countries which are subject to payment delays. Payment is dependent upon the creditworthiness of those countries and the financial stability of their economies. An allowance for doubtful accounts is maintained for accounts receivable based on the Company’s historical collection experience and expected collectability of the accounts receivable, considering the time an account is outstanding, the financial position of the customer and information provided by credit rating services. The adequacy of this allowance is reviewed each reporting period and adjusted as necessary. The allowance for doubtful accounts was $8.9 million and $8.0 million at June 26, 2016 and December 31, 2015 , respectively. The current portion of the allowance for doubtful accounts at June 26, 2016 and December 31, 2015 of $2.1 million and $2.0 million , respectively, was presented as part of accounts receivable, net. The allowance for doubtful accounts on receivables outstanding for greater than one year at June 26, 2016 and December 31, 2015 of $6.8 million and $6.0 million , respectively, was presented as part of other assets. Certain of the Company’s customers, particularly in Europe, have extended or delayed payments for products and services already provided, raising collectability concerns regarding the Company’s accounts receivable from these customers, primarily in Greece, Italy, Spain and Portugal. As a result, the Company continues to closely monitor the allowance for doubtful accounts in these locations. The aggregate net current and long-term accounts receivable for customers in Greece, Italy, Spain and Portugal and the percentage of the Company’s total net current and long-term accounts receivable represented by the net current and long-term accounts receivable for customers in those countries at June 26, 2016 and December 31, 2015 are as follows: June 26, 2016 December 31, 2015 (Dollars in thousands) Current and long-term accounts receivable (net of allowances of $7.7 million and $7.2 million at June 26, 2016 and December 31, 2015, respectively) in Greece, Italy, Spain and Portugal (1) $ 65,638 $ 62,272 Percentage of total net current and long-term accounts receivable - Greece, Italy, Spain and Portugal 23.4 % 23.9 % (1) The long-term portion of accounts receivable, net from customers in Greece, Italy, Spain and Portugal at June 26, 2016 and December 31, 2015 was $9.6 million and $8.1 million , respectively, and is reported on the condensed consolidated balance sheet in other assets. For the six months ended June 26, 2016 and June 28, 2015 , net revenues from customers in Greece, Italy, Spain and Portugal were $63.7 million and $66.2 million , respectively.

Fair value measurement

Fair value measurement	6 Months Ended
	Jun. 26, 2016
Fair Value Disclosures [Abstract]
Fair value measurement	Fair value measurement For a description of the fair value hierarchy, see Note 10 to the Company’s 2015 consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2015 . The following tables provide information regarding the Company's financial assets and liabilities that are measured at fair value on a recurring basis as of June 26, 2016 and December 31, 2015 : Total carrying Quoted prices in active markets (Level 1) Significant other Significant (Dollars in thousands) Investments in marketable securities $ 7,163 $ 7,163 $ — $ — Derivative assets 1,666 — 1,666 — Derivative liabilities 4,772 — 4,772 — Contingent consideration liabilities 21,938 — — 21,938 Total carrying Quoted prices in active markets (Level 1) Significant other Significant (Dollars in thousands) Investments in marketable securities $ 6,922 $ 6,922 $ — $ — Derivative assets 329 — 329 — Derivative liabilities 1,298 — 1,298 — Contingent consideration liabilities 20,829 — — 20,829 There were no transfers of financial assets or liabilities reported at fair value among Level 1, Level 2 or Level 3 within the fair value hierarchy during the six months ended June 26, 2016 . The following table provides information regarding changes, during the six months ended June 26, 2016 , in Level 3 financial liabilities related to contingent consideration in connection with several Company acquisitions: Contingent consideration 2016 (Dollars in thousands) Balance - December 31, 2015 $ 20,829 Payment (133 ) Revaluations 1,242 Balance - June 26, 2016 $ 21,938 Valuation Techniques The Company’s financial assets valued based upon Level 1 inputs are comprised of investments in marketable securities held in trust, which are available to satisfy benefit obligations under Company benefit plans and other arrangements. The investment assets of the trust are valued using quoted market prices. The Company’s financial assets and liabilities valued based upon Level 2 inputs are comprised of foreign currency forward contracts. The Company uses foreign currency forward contracts to manage foreign currency transaction exposure as well as exposure to foreign currency denominated monetary assets and liabilities. The Company measures the fair value of the foreign currency forward contracts by calculating the amount required to enter into offsetting contracts with similar remaining maturities, based on quoted market prices, and taking into account the creditworthiness of the counterparties. The Company’s financial liabilities valued based upon Level 3 inputs are comprised of contingent consideration arrangements pertaining to the Company’s acquisitions. The Company accounts for contingent consideration in accordance with applicable accounting guidance related to business combinations. In connection with several of its acquisitions, the Company agreed to pay contingent consideration upon the achievement of specified objectives, including receipt of regulatory approvals, commercialization of a product or achievement of sales targets, and recorded contingent consideration liabilities at the time of the acquisitions. The Company determines the fair value of the liabilities for contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market and, therefore, represents a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future payments under contingent consideration arrangements is based on several factors, including: l estimated cash flows projected from the success of market launches; l the estimated time and resources needed to complete the development of acquired technologies; l the uncertainty of obtaining regulatory approvals within the required time periods; and l the risk adjusted discount rate for fair value measurement. In connection with the Company's contingent consideration arrangements, the Company estimates that it will make payments from 2016 through 2029. As of June 26, 2016 , the range of undiscounted amounts the Company could be required to pay under contingent consideration arrangements is between $7.0 million and $46.4 million . The Company is required to reevaluate the fair value of contingent consideration each reporting period based on new developments and record changes in fair value until such consideration is satisfied through payment upon the achievement of the specified objectives or is no longer payable due to failure to achieve the specified objectives. The following table provides information regarding the valuation techniques and inputs used in determining the fair value of assets or liabilities categorized as Level 3 measurements as of June 26, 2016 : Valuation Technique Unobservable Input Range (Weighted Average) Contingent consideration Discounted cash flow Discount rate 2.6% - 10% (8.4%) Contingent consideration Probability of payment 2% - 100% (71.3%) As of June 26, 2016 , the Company recorded $21.9 million of total liabilities for contingent consideration, of which $7.5 million was recorded as the current portion of contingent consideration and $14.4 million was recorded as other liabilities in the condensed consolidated balance sheet.

Changes in shareholders' equity

Changes in shareholders' equity	6 Months Ended
	Jun. 26, 2016
Equity [Abstract]
Changes in shareholders' equity	Note 9 — Changes in shareholders’ equity Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed in the same manner except that the weighted average number of shares is increased to include dilutive securities. The following table provides a reconciliation of basic to diluted weighted average shares outstanding: Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Shares in thousands) Basic 43,549 41,560 42,598 41,514 Dilutive effect of share-based awards 566 473 543 470 Dilutive effect of 3.875% Convertible Notes and warrants 3,131 6,048 4,873 5,704 Diluted 47,246 48,081 48,014 47,688 Weighted average shares that were antidilutive and therefore not included in the calculation of earnings per share were 5.0 million and 5.1 million for the three and six months ended June 26, 2016 , respectively, and 5.6 million and 5.7 million for the three and six months ended June 28, 2015 , respectively. In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge and warrant agreements. The convertible note hedge, consisting of call options held by the Company, economically reduces the dilutive impact of the Convertible Notes. However, applicable accounting guidance requires the Company to separately address the dilutive impact of the warrants issued under the warrant agreements in computing diluted weighted average shares outstanding, without giving effect to the anti-dilutive impact of the call options. The reduction in the number of diluted shares that would result from giving effect to the anti-dilutive impact of the call options would have been 1.7 million and 2.6 million for the three and six months ended June 26, 2016 , respectively, and 3.3 million and 3.2 million for the three and six months ended June 28, 2015 , respectively. The treasury stock method is applied to the warrants when the average market price of the Company's common stock during the reporting period presented exceeds the warrant exercise price of $74.65 per share, and assumes the proceeds from the exercise of the warrants are used by the Company to repurchase shares based on such average market price. Shares issuable upon exercise of the warrants that were included in the total diluted shares outstanding were 1.5 million and 2.2 million for the three and six months ended June 26, 2016 and 2.7 million and 2.5 million for the three and six months ended June 28, 2015 , respectively. See Note 6 for information regarding the reduction in the outstanding principal amount of Convertible Notes as a result of the Company's exchange of cash and shares of common stock, as well as the conversion of a portion of the Convertible Notes, and the related reduction in the number of call options and warrants outstanding under the convertible note hedge and warrant agreements. The following tables provide information relating to the changes in accumulated other comprehensive loss, net of tax, for the six months ended June 26, 2016 and June 28, 2015 : Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance as of December 31, 2015 $ (2,491 ) $ (138,887 ) $ (229,746 ) $ (371,124 ) Other comprehensive income (loss) before reclassifications (1,684 ) 375 11,285 9,976 Amounts reclassified from accumulated other comprehensive income 2,668 2,109 — 4,777 Net current-period other comprehensive income 984 2,484 11,285 14,753 Balance as of June 26, 2016 $ (1,507 ) $ (136,403 ) $ (218,461 ) $ (356,371 ) Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance at December 31, 2014 $ — $ (141,744 ) $ (119,151 ) $ (260,895 ) Other comprehensive (loss) before reclassifications (922 ) 300 (61,893 ) (62,515 ) Amounts reclassified from accumulated other comprehensive loss 163 2,137 — 2,300 Net current-period other comprehensive (loss) income (759 ) 2,437 (61,893 ) (60,215 ) Balance at June 28, 2015 $ (759 ) $ (139,307 ) $ (181,044 ) $ (321,110 ) The following table provides information relating to the location in the statements of operations and amount of reclassifications of losses/(gains) in accumulated other comprehensive (loss) income into expense/(income), net of tax, for the three and six months ended June 26, 2016 and June 28, 2015 : Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) Losses on foreign exchange contracts: Cost of goods sold $ 1,501 $ 472 $ 3,372 $ 263 Total before tax 1,501 472 3,372 263 Tax (benefit) expense (363 ) (110 ) (704 ) (100 ) Net of tax $ 1,138 $ 362 $ 2,668 $ 163 Amortization of pension and other postretirement benefit items: Actuarial losses (1) $ 1,620 $ 1,605 $ 3,242 $ 3,211 Prior-service costs(1) 14 — 28 — Total before tax 1,634 1,605 3,270 3,211 Tax (benefit) expense (581 ) (564 ) (1,161 ) (1,074 ) Net of tax $ 1,053 $ 1,041 $ 2,109 $ 2,137 Total reclassifications, net of tax $ 2,191 $ 1,403 $ 4,777 $ 2,300 (1) These accumulated other comprehensive (loss) income components are included in the computation of net benefit expense for pension and other postretirement benefit plans (see Note 11 for additional information).

Taxes on income from continuing

Taxes on income from continuing operations	6 Months Ended
	Jun. 26, 2016
Income Tax Disclosure [Abstract]
Taxes on income from continuing operations	Note 10 — Taxes on income from continuing operations Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 Effective income tax rate 11.9% 10.5% 8.8% 14.7% The effective income tax rate for the three and six months ended June 26, 2016 was 11.9% and 8.8%, respectively, and 10.5% and 14.7% for the three and six months ended June 28, 2015, respectively. The effective income tax rate for the six months ended June 26, 2016, as compared to the prior year period, reflects a tax benefit associated with a reduction in the estimated deferred tax with respect to non-permanently reinvested income as a result of an increase in the estimated foreign tax credits available to reduce the U.S. tax on future repatriations. The effective income tax rate for the three months ended June 26, 2016 also reflects an expense associated with a shift in income to jurisdictions with higher tax rates. Additionally, the effective income tax for the six months ended June 26, 2016 reflects a tax benefit associated with the settlement of a foreign tax audit.

Pension and other postretiremen

Pension and other postretirement benefits	6 Months Ended
	Jun. 26, 2016
Compensation and Retirement Disclosure [Abstract]
Pension and other postretirement benefits	Note 11 — Pension and other postretirement benefits The Company has a number of defined benefit pension and postretirement plans covering eligible U.S. and non-U.S. employees. The defined benefit pension plans are noncontributory. The benefits under these plans are based primarily on years of service and employees’ pay near retirement. The Company’s funding policy for U.S. plans is to contribute annually, at a minimum, amounts required by applicable laws and regulations. Obligations under non-U.S. plans are systematically provided for by depositing funds with trustees or by book reserves. As of June 26, 2016 , no further benefits are being accrued under the Company’s U.S. defined benefit pension plans and the Company’s other postretirement benefit plans, other than certain postretirement benefit plans covering employees subject to a collective bargaining agreement. The Company and certain of its subsidiaries provide medical, dental and life insurance benefits to pensioners or their survivors. The associated plans are unfunded and approved claims are paid from Company funds. Net pension and other postretirement benefits expense (income) consist of the following: Pension Other Postretirement Benefits Pension Other Postretirement Benefits June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) Service cost $ 655 $ 469 $ 111 $ 107 $ 1,307 $ 940 $ 222 $ 214 Interest cost 3,929 4,485 407 511 7,849 8,971 813 1,023 Expected return on plan assets (6,199 ) (6,427 ) — — (12,397 ) (12,852 ) — — Net amortization and deferral 1,577 1,528 57 78 3,156 3,058 114 155 Net benefits expense (income) $ (38 ) $ 55 $ 575 $ 696 $ (85 ) $ 117 $ 1,149 $ 1,392 The Company’s pension contributions are required to be approximately $2.4 million during 2016, of which $1.7 million was contributed during the six months ended June 26, 2016 .

Commitments and contingent liab

Commitments and contingent liabilities	6 Months Ended
	Jun. 26, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingent liabilities	Note 12 — Commitments and contingent liabilities Operating leases: The Company uses various leased facilities and equipment in its operations. During the first quarter 2016, the Company entered into a build-to-suit lease arrangement for its European and global operations headquarters in Ireland. For accounting purposes, the Company is deemed the owner of the asset during the construction period and is required to record the estimated fair value of the incurred construction costs as construction in progress, and a current liability for those costs not funded by the Company, during the construction period. The construction of the building and tenant improvements, for which the estimated cost is $16.4 million , is expected to be completed in October 2016. The Company will occupy the entire building once construction is completed. As of June 26, 2016 , the Company recorded $8.4 million in property, plant and equipment representing the estimated fair value of the construction costs incurred to date. Based on current expectations, the Company believes it is not subject to any continuing involvement requirements that would prohibit the Company from derecognizing the asset and related liability upon commencement of the lease term. Environmental: The Company is subject to contingencies as a result of environmental laws and regulations that in the future may require the Company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the Company or other parties. Much of this liability results from the U.S. Comprehensive Environmental Response, Compensation and Liability Act, often referred to as Superfund, the U.S. Resource Conservation and Recovery Act and similar state laws. These laws require the Company to undertake certain investigative and remedial activities at sites where the Company conducts or once conducted operations or at sites where Company-generated waste was disposed. Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, the regulatory agencies involved and their enforcement policies, as well as the presence or absence of other potentially responsible parties. At June 26, 2016 , the Company has recorded $1.1 million and $6.0 million in accrued liabilities and other liabilities, respectively, relating to these matters. Considerable uncertainty exists with respect to these liabilities and, if adverse changes in circumstances occur, the potential liability may exceed the amount accrued as of June 26, 2016 . The time frame over which the accrued amounts may be paid out, based on past history, is estimated to be 15 - 20 years. Litigation: The Company is a party to various lawsuits and claims arising in the normal course of business. These lawsuits and claims include actions involving product liability, intellectual property, employment, environmental and other matters. As of June 26, 2016 , the Company has recorded accrued liabilities of $2.6 million in connection with such contingencies, representing its best estimate of the cost within the range of estimated possible losses that will be incurred to resolve these matters. Of the amount accrued as of June 26, 2016 , $1.5 million pertains to discontinued operations. In 2006, the Company was named as a defendant in a wrongful death product liability lawsuit filed in the Louisiana State District Court for the Parish of Calcasieu, involving a product manufactured by the Company’s former marine business. In September 2014, the case was tried before a jury, which returned a verdict in favor of the Company. The plaintiff subsequently filed a motion for a new trial, which was granted, and the case was re-tried before a jury in December 2014. On December 5, 2014, the jury returned a verdict in favor of the plaintiff, awarding $0.1 million in compensatory damages and $23.0 million in punitive damages, plus pre-judgment and post-judgment interest on the compensatory damages and post-judgment interest on the punitive damages. The Company's post-trial motions seeking to overturn the verdict or reduce the amount of damages were denied in June 2015. The Company appealed to the Louisiana Court of Appeal, and the plaintiff filed a cross-appeal, seeking to overturn the trial court’s denial of pre-judgment interest on the punitive damages award. On June 29, 2016, the Louisiana Court of Appeal affirmed the trial court verdict in all respects. The Company has filed a motion for rehearing with the Louisiana Court of Appeal, which currently is pending. As of June 26, 2016 , the Company has accrued a liability representing its best estimate of probable loss associated with this matter, which is included in the Company’s accrued liabilities for litigation matters relating to discontinued operations discussed in the preceding paragraph. The Company believes that any liability arising from this matter in excess of $10.0 million will be covered by the Company’s product liability insurance. Based on information currently available, advice of counsel, established reserves and other resources, the Company does not believe that the outcome of any outstanding litigation and claims is likely to be, individually or in the aggregate, material to its business, financial condition, results of operations or liquidity. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to the Company’s business, financial condition, results of operations or liquidity. Legal costs such as outside counsel fees and expenses are charged to selling, general and administrative expenses in the period incurred. Tax audits and examinations: The Company and its subsidiaries are routinely subject to tax examinations by various tax authorities. As of June 26, 2016 , the most significant tax examinations in process are in Austria and Canada. The Company may establish reserves with respect to its uncertain tax positions, after which it adjusts its reserves to address developments with respect to these uncertain tax positions. Accordingly, developments in tax audits and examinations, including resolution of uncertain tax positions, could result in increases or decreases to the Company’s recorded tax liabilities, which could impact the Company’s financial results. Other: The Company has various purchase commitments for materials, supplies and items of permanent investment incident to the ordinary conduct of its business. On average, such commitments are not at prices in excess of current market prices.

Segment information

Segment information	6 Months Ended
	Jun. 26, 2016
Segment Reporting [Abstract]
Segment information	Note 13 — Segment information An operating segment is a component of the Company (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the Company’s chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. The Company does not evaluate its operating segments using discrete asset information. The Company has the following six reportable operating segments: Vascular North America, Anesthesia North America, Surgical North America, EMEA, Asia and OEM. The Company’s reportable segments, other than the Original Equipment Manufacturer and Development Services ("OEM") segment, design, manufacture and distribute medical devices primarily used in critical care, surgical applications and cardiac care and generally serve two end markets: hospitals and healthcare providers, and home health. The products of these segments are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications. The Company’s OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Operating segments other than the reportable operating segments are collectively presented in the “All other” category within the tabular information set forth below. The following tables present the Company’s segment results for the three and six months ended June 26, 2016 and June 28, 2015 : Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) (Dollars in thousands) Revenue Vascular North America $ 88,111 $ 81,165 $ 169,699 $ 161,931 Anesthesia North America 49,194 45,579 95,151 91,028 Surgical North America 43,136 40,520 82,077 78,579 EMEA 131,705 129,132 253,800 258,414 Asia 63,191 62,042 112,347 110,571 OEM 40,298 37,918 74,275 72,633 All other 57,918 55,689 111,097 108,319 Consolidated net revenues $ 473,553 $ 452,045 $ 898,446 $ 881,475 Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) (Dollars in thousands) Operating profit Vascular North America $ 21,994 $ 17,055 $ 41,650 $ 32,805 Anesthesia North America 15,050 11,434 27,227 21,394 Surgical North America 12,348 14,315 25,604 26,642 EMEA 23,944 19,343 44,987 45,678 Asia 21,751 18,951 34,759 27,097 OEM 9,215 8,366 14,404 16,409 All other 7,436 6,855 13,179 9,948 Total segment operating profit (1) 111,738 96,319 201,810 179,973 Unallocated expenses (2) (13,297 ) (19,333 ) (35,872 ) (37,379 ) Income from continuing operations before interest and taxes $ 98,441 $ 76,986 $ 165,938 $ 142,594 (1) Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved. (2) Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.

Condensed consolidating guarant

Condensed consolidating guarantor financial information	6 Months Ended
	Jun. 26, 2016
Condensed Consolidated Guarantor Financial Information [Abstract]
Condensed consolidating guarantor financial information	Note 14 — Condensed consolidating guarantor financial information The Company's 2024 Notes and 2026 Notes are guaranteed, jointly and severally, by certain of the Parent Company’s subsidiaries (each, a “Guarantor Subsidiary” and collectively, the “Guarantor Subsidiaries”). The guarantees are full and unconditional, subject to certain customary release provisions. Each Guarantor Subsidiary is directly or indirectly 100% owned by the Parent Company. The Company’s condensed consolidating statements of income and comprehensive income (loss) for the three and six months ended June 26, 2016 and June 28, 2015 , condensed consolidating balance sheets as of June 26, 2016 and December 31, 2015 and condensed consolidating statements of cash flows for the six months ended June 26, 2016 and June 28, 2015 , provide consolidated information for: a. Parent Company, the issuer of the guaranteed obligations; b. Guarantor Subsidiaries, on a combined basis; c. Non-Guarantor Subsidiaries, on a combined basis; and d. Parent Company and its subsidiaries on a consolidated basis. The same accounting policies as described in Note 1 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 are used by the Parent Company and each of its subsidiaries in connection with the condensed consolidating financial information, except for the use of the equity method of accounting to reflect ownership interests in subsidiaries which are eliminated upon consolidation. Consolidating entries and eliminations in the following condensed consolidated financial statements represent adjustments to (a) eliminate intercompany transactions between or among the Parent Company, the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries, (b) eliminate the investments in subsidiaries and (c) record consolidating entries. TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) Three Months Ended June 26, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 280,430 $ 290,784 $ (97,661 ) $ 473,553 Cost of goods sold — 170,700 146,997 (100,543 ) 217,154 Gross profit — 109,730 143,787 2,882 256,399 Selling, general and administrative expenses 10,285 86,385 46,297 16 142,983 Research and development expenses 140 8,644 6,688 — 15,472 Restructuring charges — 557 (676 ) — (119 ) Gain on sale of assets — (378 ) — — (378 ) (Loss) income from continuing operations before interest and taxes (10,425 ) 14,522 91,478 2,866 98,441 Interest, net 33,146 (22,437 ) 1,069 — 11,778 Loss on extinguishment of debt 19,261 — — — 19,261 (Loss) income from continuing operations before taxes (62,832 ) 36,959 90,409 2,866 67,402 (Benefit) taxes on (loss) income from continuing operations (23,077 ) 14,504 15,909 671 8,007 Equity in net income of consolidated subsidiaries 99,295 63,605 175 (163,075 ) — Income from continuing operations 59,540 86,060 74,675 (160,880 ) 59,395 Operating (loss) income from discontinued operations (373 ) — 379 — 6 Tax (benefit) on (loss) income from discontinued operations (136 ) — (51 ) — (187 ) (Loss) income from discontinued operations (237 ) — 430 — 193 Net income 59,303 86,060 75,105 (160,880 ) 59,588 Less: Income from continuing operations attributable to noncontrolling interest — — 285 — 285 Net income attributable to common shareholders 59,303 86,060 74,820 (160,880 ) 59,303 Other comprehensive loss attributable to common shareholders (8,441 ) (9,685 ) (11,378 ) 21,063 (8,441 ) Comprehensive income attributable to common shareholders $ 50,862 $ 76,375 $ 63,442 $ (139,817 ) $ 50,862 Three Months Ended June 28, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed Consolidated (Dollars in thousands) Net revenues $ — $ 269,703 $ 276,258 $ (93,916 ) $ 452,045 Cost of goods sold — 158,718 152,355 (92,265 ) 218,808 Gross profit — 110,985 123,903 (1,651 ) 233,237 Selling, general and administrative expenses 8,663 82,844 50,964 (243 ) 142,228 Research and development expenses — 4,894 8,549 — 13,443 Restructuring charges — 591 (11 ) — 580 (Loss) income from continuing operations before interest and taxes (8,663 ) 22,656 64,401 (1,408 ) 76,986 Interest, net 33,358 (18,565 ) 1,260 — 16,053 Loss on extinguishment of debt 10,454 — — — 10,454 (Loss) income from continuing operations before taxes (52,475 ) 41,221 63,141 (1,408 ) 50,479 (Benefit) taxes on (loss) income from continuing operations (17,941 ) 14,917 8,463 (159 ) 5,280 Equity in net income of consolidated subsidiaries 79,246 51,964 122 (131,332 ) — Income from continuing operations 44,712 78,268 54,800 (132,581 ) 45,199 Operating loss from discontinued operations (145 ) — — — (145 ) Taxes on loss from discontinued operations 4 — 41 — 45 Loss from discontinued operations (149 ) — (41 ) — (190 ) Net income 44,563 78,268 54,759 (132,581 ) 45,009 Less: Income from continuing operations attributable to noncontrolling interest — — 446 — 446 Net income attributable to common shareholders 44,563 78,268 54,313 (132,581 ) 44,563 Other comprehensive income attributable to common shareholders 20,986 45,015 24,340 (69,355 ) 20,986 Comprehensive income attributable to common shareholders $ 65,549 $ 123,283 $ 78,653 $ (201,936 ) $ 65,549 Six Months Ended June 26, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 539,341 $ 552,132 $ (193,027 ) $ 898,446 Cost of goods sold — 326,241 279,960 (189,301 ) 416,900 Gross profit — 213,100 272,172 (3,726 ) 481,546 Selling, general and administrative expenses 19,614 167,862 91,356 499 279,331 Research and development expenses 140 15,079 12,606 — 27,825 Restructuring charges — 5,315 4,534 — 9,849 Gain on sale of assets — (378 ) (1,019 ) — (1,397 ) (Loss) income from continuing operations before interest and taxes (19,754 ) 25,222 164,695 (4,225 ) 165,938 Interest, net 66,190 (42,755 ) 2,047 — 25,482 Loss on extinguishment of debt 19,261 — — — 19,261 (Loss) income from continuing operations before taxes (105,205 ) 67,977 162,648 (4,225 ) 121,195 (Benefit) taxes on (loss) income from continuing operations (38,925 ) 26,181 23,773 (409 ) 10,620 Equity in net income of consolidated subsidiaries 176,752 121,505 343 (298,600 ) — Income from continuing operations 110,472 163,301 139,218 (302,416 ) 110,575 Operating (loss) income from discontinued operations (755 ) — 379 — (376 ) (Benefit) taxes on (loss) income from discontinued operations (275 ) — 18 — (257 ) (Loss) income from discontinued operations (480 ) — 361 — (119 ) Net income 109,992 163,301 139,579 (302,416 ) 110,456 Less: Income from continuing operations attributable to noncontrolling interest — — 464 — 464 Net income attributable to common shareholders 109,992 163,301 139,115 (302,416 ) 109,992 Other comprehensive income attributable to common shareholders 14,753 8,888 11,034 (19,922 ) 14,753 Comprehensive income attributable to common shareholders $ 124,745 $ 172,189 $ 150,149 $ (322,338 ) $ 124,745 Six Months Ended June 28, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 533,864 $ 535,159 $ (187,548 ) $ 881,475 Cost of goods sold — 317,044 289,973 (181,416 ) 425,601 Gross profit — 216,820 245,186 (6,132 ) 455,874 Selling, general and administrative expenses 20,115 167,112 94,781 (83 ) 281,925 Research and development expenses — 16,021 10,306 — 26,327 Restructuring charges — 4,330 698 — 5,028 (Loss) income from continuing operations before interest and taxes (20,115 ) 29,357 139,401 (6,049 ) 142,594 Interest, net 67,718 (37,134 ) 2,472 — 33,056 Loss on extinguishment of debt 10,454 — — — 10,454 (Loss) income from continuing operations before taxes (98,287 ) 66,491 136,929 (6,049 ) 99,084 (Benefit) taxes on (loss) income from continuing operations (33,234 ) 25,909 23,207 (1,270 ) 14,612 Equity in net income of consolidated subsidiaries 148,784 111,654 219 (260,657 ) — Income from continuing operations 83,731 152,236 113,941 (265,436 ) 84,472 Operating (loss) income from discontinued operations (648 ) — 4 — (644 ) Taxes on (loss) income from discontinued operations 168 — 81 — 249 Loss from discontinued operations (816 ) — (77 ) — (893 ) Net income 82,915 152,236 113,864 (265,436 ) 83,579 Less: Income from continuing operations attributable to noncontrolling interest — — 664 — 664 Net income attributable to common shareholders 82,915 152,236 113,200 (265,436 ) 82,915 Other comprehensive loss attributable to common shareholders (60,215 ) (61,746 ) (75,388 ) 137,134 (60,215 ) Comprehensive income attributable to common shareholders $ 22,700 $ 90,490 $ 37,812 $ (128,302 ) $ 22,700 TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS June 26, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 50,209 $ 1,089 $ 425,192 $ — $ 476,490 Accounts receivable, net 3,139 4,832 261,674 3,885 273,530 Accounts receivable from consolidated subsidiaries 4,914 2,363,862 308,587 (2,677,363 ) — Inventories, net — 203,774 163,045 (28,354 ) 338,465 Prepaid expenses and other current assets 10,289 5,993 15,894 3,665 35,841 Prepaid taxes 8,579 — 21,790 — 30,369 Assets held for sale 2,901 — 4,125 — 7,026 Total current assets 80,031 2,579,550 1,200,307 (2,698,167 ) 1,161,721 Property, plant and equipment, net 2,771 166,228 145,666 — 314,665 Goodwill — 705,754 595,594 — 1,301,348 Intangibles assets, net — 724,239 450,859 — 1,175,098 Investments in affiliates 5,913,792 1,488,669 23,383 (7,425,600 ) 244 Deferred tax assets 86,886 — 6,235 (91,136 ) 1,985 Notes receivable and other amounts due from consolidated subsidiaries 1,353,481 1,786,335 — (3,139,816 ) — Other assets 22,443 6,697 16,006 — 45,146 Total assets $ 7,459,404 $ 7,457,472 $ 2,438,050 $ (13,354,719 ) $ 4,000,207 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 130,652 $ — $ 43,300 $ — $ 173,952 Accounts payable 3,802 34,362 34,623 — 72,787 Accounts payable to consolidated subsidiaries 2,423,041 221,128 33,194 (2,677,363 ) — Accrued expenses 14,963 17,361 31,072 — 63,396 Current portion of contingent consideration — 7,453 — — 7,453 Payroll and benefit-related liabilities 19,447 17,637 33,975 — 71,059 Accrued interest 5,670 — 18 — 5,688 Income taxes payable — — 13,038 (81 ) 12,957 Other current liabilities 4,777 2,157 9,578 — 16,512 Total current liabilities 2,602,352 300,098 198,798 (2,677,444 ) 423,804 Long-term borrowings 907,930 — — — 907,930 Deferred tax liabilities — 372,650 35,813 (91,136 ) 317,327 Pension and other postretirement benefit liabilities 95,719 32,004 16,269 — 143,992 Noncurrent liability for uncertain tax positions 1,503 17,825 7,087 — 26,415 Notes payable and other amounts due to consolidated subsidiaries 1,709,543 1,231,819 198,454 (3,139,816 ) — Other liabilities 23,007 23,505 12,659 — 59,171 Total liabilities 5,340,054 1,977,901 469,080 (5,908,396 ) 1,878,639 Total common shareholders' equity 2,119,350 5,479,571 1,966,752 (7,446,323 ) 2,119,350 Noncontrolling interest — — 2,218 — 2,218 Total equity 2,119,350 5,479,571 1,968,970 (7,446,323 ) 2,121,568 Total liabilities and equity $ 7,459,404 $ 7,457,472 $ 2,438,050 $ (13,354,719 ) $ 4,000,207 December 31, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 21,612 $ — $ 316,754 $ — $ 338,366 Accounts receivable, net 2,538 4,326 251,166 4,386 262,416 Accounts receivable from consolidated subsidiaries 5,276 2,412,079 289,697 (2,707,052 ) — Inventories, net — 205,163 149,705 (24,593 ) 330,275 Prepaid expenses and other current assets 10,511 4,702 16,037 3,665 34,915 Prepaid taxes 16,686 — 14,622 (413 ) 30,895 Assets held for sale 2,901 — 4,071 — 6,972 Total current assets 59,524 2,626,270 1,042,052 (2,724,007 ) 1,003,839 Property, plant and equipment, net 2,931 174,674 138,518 — 316,123 Goodwill — 705,753 590,099 — 1,295,852 Intangibles assets, net — 762,084 437,891 — 1,199,975 Investments in affiliates 5,724,226 1,360,045 23,065 (7,107,184 ) 152 Deferred tax assets 91,432 — 8,042 (97,133 ) 2,341 Notes receivable and other amounts due from consolidated subsidiaries 1,358,446 1,658,092 — (3,016,538 ) — Other assets 22,602 6,615 24,275 — 53,492 Total assets $ 7,259,161 $ 7,293,533 $ 2,263,942 $ (12,944,862 ) $ 3,871,774 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 374,050 $ — $ 43,300 $ — $ 417,350 Accounts payable 1,945 27,527 36,833 — 66,305 Accounts payable to consolidated subsidiaries 2,478,109 201,400 27,543 (2,707,052 ) — Accrued expenses 15,399 22,281 26,337 — 64,017 Current portion of contingent consideration — 7,291 — — 7,291 Payroll and benefit-related liabilities 21,617 29,305 33,736 — 84,658 Accrued interest 7,455 — 25 — 7,480 Income taxes payable — — 8,144 (85 ) 8,059 Other current liabilities 1,300 2,679 4,981 — 8,960 Total current liabilities 2,899,875 290,483 180,899 (2,707,137 ) 664,120 Long-term borrowings 641,850 — — — 641,850 Deferred tax liabilities — 376,738 36,378 (97,133 ) 315,983 Pension and other postretirement benefit liabilities 100,355 32,274 16,812 — 149,441 Noncurrent liability for uncertain tax positions 1,151 17,722 21,527 — 40,400 Notes payable and other amounts due to consolidated subsidiaries 1,585,727 1,253,189 177,622 (3,016,538 ) — Other liabilities 20,931 15,685 12,271 — 48,887 Total liabilities 5,249,889 1,986,091 445,509 (5,820,808 ) 1,860,681 Total common shareholders' equity 2,009,272 5,307,442 1,816,612 (7,124,054 ) 2,009,272 Noncontrolling interest — — 1,821 — 1,821 Total equity 2,009,272 5,307,442 1,818,433 (7,124,054 ) 2,011,093 Total liabilities and equity $ 7,259,161 $ 7,293,533 $ 2,263,942 $ (12,944,862 ) $ 3,871,774 TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Six Months Ended June 26, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (29,648 ) $ 69,875 $ 141,261 $ — $ 181,488 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (146 ) (9,947 ) (9,442 ) — (19,535 ) Proceeds from sale of assets — 20,642 1,251 (17,908 ) 3,985 Payments for businesses and intangibles acquired, net of cash acquired — — (21,025 ) 17,908 (3,117 ) Net cash used in investing activities from continuing operations (146 ) 10,695 (29,216 ) — (18,667 ) Cash flows from financing activities of continuing operations: Proceeds from new borrowings 665,000 — — — 665,000 Reduction in borrowings (656,479 ) — — — (656,479 ) Debt extinguishment, issuance and amendment fees (8,182 ) — — — (8,182 ) Net proceeds from share based compensation plans and the related tax impacts 6,593 — — — 6,593 Payments for contingent consideration — (133 ) — — (133 ) Dividends paid (28,998 ) — — — (28,998 ) Intercompany transactions 81,640 (79,348 ) (2,292 ) — — Net cash provided by (used in) financing activities from continuing operations 59,574 (79,481 ) (2,292 ) — (22,199 ) Cash flows from discontinued operations: Net cash used in operating activities (1,183 ) — — — (1,183 ) Net cash used in discontinued operations (1,183 ) — — — (1,183 ) Effect of exchange rate changes on cash and cash equivalents — — (1,315 ) — (1,315 ) Net increase in cash and cash equivalents 28,597 1,089 108,438 — 138,124 Cash and cash equivalents at the beginning of the period 21,612 — 316,754 — 338,366 Cash and cash equivalents at the end of the period $ 50,209 $ 1,089 $ 425,192 $ — $ 476,490 Six Months Ended June 28, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (92,490 ) $ 63,718 $ 140,720 $ (2,360 ) $ 109,588 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (108 ) (17,339 ) (13,874 ) — (31,321 ) Payments for businesses and intangibles acquired, net of cash acquired — (4,348 ) (33,211 ) — (37,559 ) Net cash used in investing activities from continuing operations (108 ) (21,687 ) (47,085 ) — (68,880 ) Cash flows from financing activities of continuing operations: Proceeds from new borrowings 288,100 — — — 288,100 Reduction in borrowings (250,981 ) — — — (250,981 ) Debt extinguishment, issuance and amendment fees (8,746 ) — — — (8,746 ) Net proceeds from share based compensation plans and the related tax impacts 4,843 — — — 4,843 Payments to noncontrolling interest shareholders — — (832 ) — (832 ) Payments for contingent consideration — (3,989 ) — — (3,989 ) Dividends paid (28,234 ) — — — (28,234 ) Intercompany transactions 86,197 (37,744 ) (48,453 ) — — Intercompany dividends paid — — (2,360 ) 2,360 — Net cash provided by (used in) financing activities from continuing operations 91,179 (41,733 ) (51,645 ) 2,360 161 Cash flows from discontinued operations: Net cash used in operating activities (514 ) — (849 ) — (1,363 ) Net cash used in discontinued operations (514 ) — (849 ) — (1,363 ) Effect of exchange rate changes on cash and cash equivalents — — (17,732 ) — (17,732 ) Net (decrease) increase in cash and cash equivalents (1,933 ) 298 23,409 — 21,774 Cash and cash equivalents at the beginning of the period 27,996 — 275,240 — 303,236 Cash and cash equivalents at the end of the period $ 26,063 $ 298 $ 298,649 $ — $ 325,010

New accounting standards (Polic

New accounting standards (Policies)	6 Months Ended
	Jun. 26, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New accounting standards	New accounting standards In May 2014, the Financial Accounting Standards Board ("FASB"), in a joint effort with the International Accounting Standards Board ("IASB"), issued new accounting guidance to clarify the principles for recognizing revenue. The new guidance is designed to enhance the comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, and will affect any entity that enters into contracts with customers or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards. The new guidance establishes principles for reporting information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity's contracts with customers. The core principle of the new guidance is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued an amendment to the new guidance that defers the effective date. The amendment provides that the new guidance is effective prospectively for annual periods beginning after December 15, 2017 and interim periods within those years; early application is permitted for annual periods beginning after December 15, 2016. The Company is currently evaluating this guidance to determine its impact on the Company’s results of operations, cash flows and financial position. In April 2015, the FASB issued guidance for the reporting of debt issuance costs within the balance sheet. Under the new guidance, debt issuance costs related to term loans are to be presented in the balance sheet as a direct deduction from the associated debt liability, consistent with the presentation of a debt discount. Previously, debt issuance costs were presented as a deferred charge (i.e., an asset) on the balance sheet. The guidance provides uniform treatment for debt issuance costs and debt discounts and eliminates inconsistencies that previously existed with other FASB guidance. The Company retrospectively adopted this guidance as of January 1, 2016. In February 2016, the FASB issued guidance that will change the requirements for accounting for leases. The principal change under the new accounting guidance is that lessees under leases classified as operating leases will recognize a right-of-use asset and a lease liability. Current lease accounting does not require lessees to recognize assets and liabilities arising under operating leases on the balance sheet. Under the new guidance, lessees (including lessees under leases classified as finance leases and operating leases) will recognize a right-to-use asset and a lease liability on the balance sheet, initially measured as the present value of lease payments under the lease. Expense recognition and cash flow presentation guidance will be based upon whether the lease is classified as an operating lease or a finance lease (the classification criteria for distinguishing between finance leases and operating leases is substantially similar to the classification criteria for distinguishing between capital leases and operating leases under current guidance). The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition approach for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements; the guidance provides certain practical expedients. The Company is currently evaluating this guidance to determine its impact on the Company’s results of operations, cash flows and financial position. In March 2016, the FASB issued new guidance designed to simplify several aspects of the accounting for share-based payment transactions, including guidance providing generally that excess tax benefits related to share-based awards should be recorded as a reduction to income tax expense (currently, excess tax benefits generally are recorded as additional-paid-in-capital) and addressing other, related guidance on accounting for income taxes with respect to share-based payment awards; providing generally that excess tax benefits related to share-based awards should be classified along with other income tax cash flows as an operating activity (currently, excess tax benefits generally are separated from other income tax cash flows and classified as a financing activity); providing that an entity may make an accounting policy election either to base compensation cost accruals on the number of awards expected to vest (as required by current guidance) or to account for forfeitures when they occur; modifying the current exception to liability classification such that partial cash settlement of an award for tax withholding purposes would not result, by itself, in liability classification of the award if the amount withheld does not exceed the maximum statutory tax rate in the employees' applicable jurisdictions (currently, an award cannot qualify for equity classification, rather than liability classification, if the amount withheld exceeds the minimum statutory withholding requirements); and providing that cash paid by an employer when directly withholding shares for tax withholding purposes should be classified as a financing activity on the statement of cash flows (currently there is no authoritative guidance addressing this classification issue). The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted (if early adoption occurs in an interim period, any adjustments will be reflected as of the beginning of the fiscal year that includes the interim period). Depending on the particular issue addressed by the guidance, application of the guidance will be made prospectively, retrospectively or subject to a retrospective transition method. We are currently evaluating the potential impact of adopting this guidance on the Company's results of operations, cash flows and financial position. From time to time, new accounting guidance is issued by the FASB or other standard setting bodies that is adopted by the Company as of the effective date or, in some cases where early adoption is permitted, in advance of the effective date. The Company has assessed the recently issued guidance that is not yet effective and, unless otherwise indicated above, believes the new guidance will not have a material impact on the Company’s results of operations, cash flows or financial position.

Restructuring charges (Tables)

Restructuring charges (Tables)	6 Months Ended
	Jun. 26, 2016
Restructuring and Related Activities [Abstract]
Summary of Current Cost Estimates by Major Type of Cost Associated with 2014 Manufacturing Footprint Realignment Plan	The following table provides a summary of the Company's current cost estimates for each major expense category associated with the 2016 Plan: Type of expense Total estimated amount expected to be incurred Employee termination benefits $14 million to $18 million Facility closure and other exit costs (1) $2 million to $3 million Accelerated depreciation charges $10 million to $13 million Other (2) $8 million to $10 million $34 million to $44 million (1) Includes costs to transfer product lines among facilities, legal, outplacement and employee relocation costs. (2) Consists of other costs directly related to the 2016 Plan, including project management and other regulatory costs.
Restructuring and Other Impairment Charges	Restructuring charges by reportable operating segment for the three and six months ended June 26, 2016 and June 28, 2015 are set forth in the following table: Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) (Dollars in thousands) Restructuring charges Vascular North America $ 351 $ 520 $ 4,514 $ 2,783 Anesthesia North America 364 (2 ) 2,239 534 Surgical North America — — (20 ) 246 EMEA (949 ) (43 ) 2,923 (75 ) Asia (2 ) 1 — 1 OEM (1 ) — 4 — All other 118 104 189 1,539 Total restructuring charges $ (119 ) $ 580 $ 9,849 $ 5,028 The restructuring charges recognized for the three and six months ended June 26, 2016 and June 28, 2015 consisted of the following: Three Months Ended June 26, 2016 (in thousands) Termination Benefits Facility Closure Costs Contract Termination Costs Other Exit Costs Total 2016 Manufacturing footprint realignment plan $ (279 ) $ — $ — $ 286 $ 7 2015 Restructuring programs (442 ) 55 115 25 (247 ) 2014 Manufacturing footprint realignment plan 112 — — 9 121 Total restructuring charges $ (609 ) $ 55 $ 115 $ 320 $ (119 ) Three Months Ended June 28, 2015 (in thousands) Termination Benefits Facility Contract Termination Costs Other Exit Costs Total 2015 Restructuring programs $ 9 $ 63 $ 24 $ 46 $ 142 2014 Manufacturing footprint realignment plan 75 204 228 — 507 Other restructuring programs - prior years (1) (96 ) — 9 18 (69 ) Total restructuring charges $ (12 ) $ 267 $ 261 $ 64 $ 580 Six Months Ended June 26, 2016 (in thousands) Termination Benefits Facility Contract Termination Costs Other Exit Costs Total 2016 Manufacturing footprint realignment plan $ 10,068 $ — $ — $ 286 $ 10,354 2015 Restructuring programs (399 ) 178 93 118 (10 ) 2014 Manufacturing footprint realignment plan (426 ) — — 11 (415 ) Other restructuring programs - prior years (1) — — (86 ) 6 (80 ) Total restructuring charges $ 9,243 $ 178 $ 7 $ 421 $ 9,849 Six Months Ended June 28, 2015 (in thousands) Termination Benefits Facility Closure Costs Contract Termination Costs Other Exit Costs Total 2015 Restructuring programs $ 3,559 $ 129 $ 645 $ 47 $ 4,380 2014 Manufacturing footprint realignment 212 230 228 — 670 Other restructuring programs - prior years (1) (85 ) — 28 35 (22 ) Total restructuring charges $ 3,686 $ 359 $ 901 82 $ 5,028 (1) Other restructuring programs - prior years includes the 2014 European Restructuring Plan, the Other 2014 restructuring programs, the 2013 Restructuring programs and the LMA restructuring program. For a description of these plans, see Note 4 to the Company’s consolidated financial statements included in its annual report on Form 10-K for the year ended December 31, 2015.

Inventories, net (Tables)

Inventories, net (Tables)	6 Months Ended
	Jun. 26, 2016
Inventory Disclosure [Abstract]
Inventories, net	Inventories as of June 26, 2016 and December 31, 2015 consisted of the following: June 26, 2016 December 31, 2015 (Dollars in thousands) Raw materials $ 79,199 $ 76,037 Work-in-process 57,129 60,218 Finished goods 239,161 230,536 375,489 366,791 Less: inventory reserve (37,024 ) (36,516 ) Inventories, net $ 338,465 $ 330,275

Goodwill and other intangible26

Goodwill and other intangible assets, net (Tables)	6 Months Ended
	Jun. 26, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill, by Reporting Segment	The following table provides information relating to changes in the carrying amount of goodwill by reportable segment for the six months ended June 26, 2016 : Vascular Anesthesia Surgical EMEA Asia OEM All Total (Dollars in thousands) Balance as of December 31, 2015 $ 345,546 $ 141,122 $ 250,912 $ 306,009 $ 141,067 $ 1,194 $ 110,002 $ 1,295,852 Currency translation adjustment — 405 — 367 6,864 — (2,140 ) 5,496 Balance as of June 26, 2016 $ 345,546 $ 141,527 $ 250,912 $ 306,376 $ 147,931 $ 1,194 $ 107,862 $ 1,301,348
Components of Intangible Assets	The following table provides information as of June 26, 2016 and December 31, 2015 regarding the gross carrying amount of, and accumulated amortization relating to, intangible assets, net: Gross Carrying Amount Accumulated Amortization June 26, 2016 December 31, 2015 June 26, 2016 December 31, 2015 (Dollars in thousands) Customer relationships $ 624,851 $ 621,078 $ (228,493 ) $ (214,924 ) In-process research and development 58,614 58,908 — — Intellectual property 523,189 522,374 (189,454 ) (173,903 ) Distribution rights 23,340 23,279 (15,005 ) (14,393 ) Trade names 387,388 384,821 (11,466 ) (8,929 ) Non-compete agreements 2,846 2,186 (712 ) (522 ) $ 1,620,228 $ 1,612,646 $ (445,130 ) $ (412,671 )

Borrowings (Tables)

Borrowings (Tables)	6 Months Ended
	Jun. 26, 2016
Debt Disclosure [Abstract]
Components of Long-Term Debt	The Company's borrowings at June 26, 2016 and December 31, 2015 are as follows: June 26, 2016 December 31, 2015 (Dollars in thousands) Senior Credit Facility: Revolving credit facility, at a rate of 1.95% at June 26, 2016, due 2018 $ 268,000 $ 396,000 3.875% Convertible Senior Subordinated Notes due 2017 136,162 399,641 4.875% Senior Notes due 2026 400,000 — 5.25% Senior Notes due 2024 250,000 250,000 Securitization program, at a rate of 1.20% at June 26, 2016 43,300 43,300 1,097,462 1,088,941 Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes due 2017 (4,956 ) (22,999 ) Less: Unamortized debt issuance costs (10,624 ) (6,742 ) 1,081,882 1,059,200 Current borrowings (173,952 ) (417,350 ) Long-term borrowings $ 907,930 $ 641,850
Fair Value of Long-Term Debt	The following table provides the fair value of the Company’s debt as of June 26, 2016 and December 31, 2015, categorized by the level of inputs within the fair value hierarchy used to measure fair value (see Note 10, “Fair value measurement,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 for further information): June 26, 2016 December 31, 2015 (Dollars in thousands) Level 1 $ 389,423 $ 858,709 Level 2 987,010 687,072 Total $ 1,376,433 $ 1,545,781

Financial instruments (Tables)

Financial instruments (Tables)	6 Months Ended
	Jun. 26, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Values of Derivative Instruments Designated as Hedging Instruments	The following table presents the location and fair value of derivative financial instruments reported in the condensed consolidated balance sheet as of June 26, 2016 and December 31, 2015 : June 26, 2016 December 31, 2015 Fair Value Fair Value (Dollars in thousands) Asset derivatives: Designated foreign currency forward contracts $ 1,211 $ 285 Non-designated foreign currency forward contracts 455 44 Prepaid expenses and other current assets $ 1,666 $ 329 Total asset derivatives $ 1,666 $ 329 Liability derivatives: Designated foreign currency forward contracts $ 3,366 $ 807 Non-designated foreign currency forward contracts 1,406 491 Other current liabilities $ 4,772 $ 1,298 Total liability derivatives $ 4,772 $ 1,298
After Tax Gain/(Loss) Recognized in OCI	The following table provides information as to the gains and losses attributable to derivatives in cash flow hedging relationships that were reported in other comprehensive income (loss) (“OCI”) for the three and six months ended June 26, 2016 and June 28, 2015 : After Tax Gain (Loss) Recognized in OCI Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) Foreign currency forward contracts $ (496 ) $ (803 ) $ 984 $ (759 ) Total $ (496 ) $ (803 ) $ 984 $ (759 )
Aggregate Accounts Receivable, Net of Allowance for Doubtful Accounts	The aggregate net current and long-term accounts receivable for customers in Greece, Italy, Spain and Portugal and the percentage of the Company’s total net current and long-term accounts receivable represented by the net current and long-term accounts receivable for customers in those countries at June 26, 2016 and December 31, 2015 are as follows: June 26, 2016 December 31, 2015 (Dollars in thousands) Current and long-term accounts receivable (net of allowances of $7.7 million and $7.2 million at June 26, 2016 and December 31, 2015, respectively) in Greece, Italy, Spain and Portugal (1) $ 65,638 $ 62,272 Percentage of total net current and long-term accounts receivable - Greece, Italy, Spain and Portugal 23.4 % 23.9 % (1) The long-term portion of accounts receivable, net from customers in Greece, Italy, Spain and Portugal at June 26, 2016 and December 31, 2015 was $9.6 million and $8.1 million , respectively, and is reported on the condensed consolidated balance sheet in other assets.

Fair value measurement (Tables)

Fair value measurement (Tables)	6 Months Ended
	Jun. 26, 2016
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities Carried at Fair Value Measured on Recurring Basis	The following tables provide information regarding the Company's financial assets and liabilities that are measured at fair value on a recurring basis as of June 26, 2016 and December 31, 2015 : Total carrying Quoted prices in active markets (Level 1) Significant other Significant (Dollars in thousands) Investments in marketable securities $ 7,163 $ 7,163 $ — $ — Derivative assets 1,666 — 1,666 — Derivative liabilities 4,772 — 4,772 — Contingent consideration liabilities 21,938 — — 21,938 Total carrying Quoted prices in active markets (Level 1) Significant other Significant (Dollars in thousands) Investments in marketable securities $ 6,922 $ 6,922 $ — $ — Derivative assets 329 — 329 — Derivative liabilities 1,298 — 1,298 — Contingent consideration liabilities 20,829 — — 20,829
Reconciliation of Changes in Level 3 Financial Liabilities Measured at Fair Value on Recurring Basis	The following table provides information regarding changes, during the six months ended June 26, 2016 , in Level 3 financial liabilities related to contingent consideration in connection with several Company acquisitions: Contingent consideration 2016 (Dollars in thousands) Balance - December 31, 2015 $ 20,829 Payment (133 ) Revaluations 1,242 Balance - June 26, 2016 $ 21,938
Valuation Technique and Inputs Used to Determine Fair Value of Assets or Liabilities	The following table provides information regarding the valuation techniques and inputs used in determining the fair value of assets or liabilities categorized as Level 3 measurements as of June 26, 2016 : Valuation Technique Unobservable Input Range (Weighted Average) Contingent consideration Discounted cash flow Discount rate 2.6% - 10% (8.4%) Contingent consideration Probability of payment 2% - 100% (71.3%)

Changes in shareholders' equi30

Changes in shareholders' equity (Tables)	6 Months Ended
	Jun. 26, 2016
Equity [Abstract]
Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding	The following table provides a reconciliation of basic to diluted weighted average shares outstanding: Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Shares in thousands) Basic 43,549 41,560 42,598 41,514 Dilutive effect of share-based awards 566 473 543 470 Dilutive effect of 3.875% Convertible Notes and warrants 3,131 6,048 4,873 5,704 Diluted 47,246 48,081 48,014 47,688
Change in Accumulated Other Comprehensive Income (Loss)	The following tables provide information relating to the changes in accumulated other comprehensive loss, net of tax, for the six months ended June 26, 2016 and June 28, 2015 : Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance as of December 31, 2015 $ (2,491 ) $ (138,887 ) $ (229,746 ) $ (371,124 ) Other comprehensive income (loss) before reclassifications (1,684 ) 375 11,285 9,976 Amounts reclassified from accumulated other comprehensive income 2,668 2,109 — 4,777 Net current-period other comprehensive income 984 2,484 11,285 14,753 Balance as of June 26, 2016 $ (1,507 ) $ (136,403 ) $ (218,461 ) $ (356,371 ) Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance at December 31, 2014 $ — $ (141,744 ) $ (119,151 ) $ (260,895 ) Other comprehensive (loss) before reclassifications (922 ) 300 (61,893 ) (62,515 ) Amounts reclassified from accumulated other comprehensive loss 163 2,137 — 2,300 Net current-period other comprehensive (loss) income (759 ) 2,437 (61,893 ) (60,215 ) Balance at June 28, 2015 $ (759 ) $ (139,307 ) $ (181,044 ) $ (321,110 )
Reclassification of Gain/Losses into Income/Expense, Net of Tax	The following table provides information relating to the location in the statements of operations and amount of reclassifications of losses/(gains) in accumulated other comprehensive (loss) income into expense/(income), net of tax, for the three and six months ended June 26, 2016 and June 28, 2015 : Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) Losses on foreign exchange contracts: Cost of goods sold $ 1,501 $ 472 $ 3,372 $ 263 Total before tax 1,501 472 3,372 263 Tax (benefit) expense (363 ) (110 ) (704 ) (100 ) Net of tax $ 1,138 $ 362 $ 2,668 $ 163 Amortization of pension and other postretirement benefit items: Actuarial losses (1) $ 1,620 $ 1,605 $ 3,242 $ 3,211 Prior-service costs(1) 14 — 28 — Total before tax 1,634 1,605 3,270 3,211 Tax (benefit) expense (581 ) (564 ) (1,161 ) (1,074 ) Net of tax $ 1,053 $ 1,041 $ 2,109 $ 2,137 Total reclassifications, net of tax $ 2,191 $ 1,403 $ 4,777 $ 2,300 (1) These accumulated other comprehensive (loss) income components are included in the computation of net benefit expense for pension and other postretirement benefit plans (see Note 11 for additional information).

Taxes on income from continui31

Taxes on income from continuing operations (Tables)	6 Months Ended
	Jun. 26, 2016
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 Effective income tax rate 11.9% 10.5% 8.8% 14.7%

Pension and other postretirem32

Pension and other postretirement benefits (Tables)	6 Months Ended
	Jun. 26, 2016
Compensation and Retirement Disclosure [Abstract]
Net Benefit Cost of Pension and Postretirement Benefit Plans	Net pension and other postretirement benefits expense (income) consist of the following: Pension Other Postretirement Benefits Pension Other Postretirement Benefits June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) Service cost $ 655 $ 469 $ 111 $ 107 $ 1,307 $ 940 $ 222 $ 214 Interest cost 3,929 4,485 407 511 7,849 8,971 813 1,023 Expected return on plan assets (6,199 ) (6,427 ) — — (12,397 ) (12,852 ) — — Net amortization and deferral 1,577 1,528 57 78 3,156 3,058 114 155 Net benefits expense (income) $ (38 ) $ 55 $ 575 $ 696 $ (85 ) $ 117 $ 1,149 $ 1,392

Segment information (Tables)

Segment information (Tables)	6 Months Ended
	Jun. 26, 2016
Segment Reporting [Abstract]
Segment Results	The following tables present the Company’s segment results for the three and six months ended June 26, 2016 and June 28, 2015 : Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) (Dollars in thousands) Revenue Vascular North America $ 88,111 $ 81,165 $ 169,699 $ 161,931 Anesthesia North America 49,194 45,579 95,151 91,028 Surgical North America 43,136 40,520 82,077 78,579 EMEA 131,705 129,132 253,800 258,414 Asia 63,191 62,042 112,347 110,571 OEM 40,298 37,918 74,275 72,633 All other 57,918 55,689 111,097 108,319 Consolidated net revenues $ 473,553 $ 452,045 $ 898,446 $ 881,475 Three Months Ended Six Months Ended June 26, 2016 June 28, 2015 June 26, 2016 June 28, 2015 (Dollars in thousands) (Dollars in thousands) Operating profit Vascular North America $ 21,994 $ 17,055 $ 41,650 $ 32,805 Anesthesia North America 15,050 11,434 27,227 21,394 Surgical North America 12,348 14,315 25,604 26,642 EMEA 23,944 19,343 44,987 45,678 Asia 21,751 18,951 34,759 27,097 OEM 9,215 8,366 14,404 16,409 All other 7,436 6,855 13,179 9,948 Total segment operating profit (1) 111,738 96,319 201,810 179,973 Unallocated expenses (2) (13,297 ) (19,333 ) (35,872 ) (37,379 ) Income from continuing operations before interest and taxes $ 98,441 $ 76,986 $ 165,938 $ 142,594 (1) Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved. (2) Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.

Condensed consolidating guara34

Condensed consolidating guarantor financial information (Tables)	6 Months Ended
	Jun. 26, 2016
Condensed Consolidated Guarantor Financial Information [Abstract]
Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)	TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) Three Months Ended June 26, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 280,430 $ 290,784 $ (97,661 ) $ 473,553 Cost of goods sold — 170,700 146,997 (100,543 ) 217,154 Gross profit — 109,730 143,787 2,882 256,399 Selling, general and administrative expenses 10,285 86,385 46,297 16 142,983 Research and development expenses 140 8,644 6,688 — 15,472 Restructuring charges — 557 (676 ) — (119 ) Gain on sale of assets — (378 ) — — (378 ) (Loss) income from continuing operations before interest and taxes (10,425 ) 14,522 91,478 2,866 98,441 Interest, net 33,146 (22,437 ) 1,069 — 11,778 Loss on extinguishment of debt 19,261 — — — 19,261 (Loss) income from continuing operations before taxes (62,832 ) 36,959 90,409 2,866 67,402 (Benefit) taxes on (loss) income from continuing operations (23,077 ) 14,504 15,909 671 8,007 Equity in net income of consolidated subsidiaries 99,295 63,605 175 (163,075 ) — Income from continuing operations 59,540 86,060 74,675 (160,880 ) 59,395 Operating (loss) income from discontinued operations (373 ) — 379 — 6 Tax (benefit) on (loss) income from discontinued operations (136 ) — (51 ) — (187 ) (Loss) income from discontinued operations (237 ) — 430 — 193 Net income 59,303 86,060 75,105 (160,880 ) 59,588 Less: Income from continuing operations attributable to noncontrolling interest — — 285 — 285 Net income attributable to common shareholders 59,303 86,060 74,820 (160,880 ) 59,303 Other comprehensive loss attributable to common shareholders (8,441 ) (9,685 ) (11,378 ) 21,063 (8,441 ) Comprehensive income attributable to common shareholders $ 50,862 $ 76,375 $ 63,442 $ (139,817 ) $ 50,862 Three Months Ended June 28, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed Consolidated (Dollars in thousands) Net revenues $ — $ 269,703 $ 276,258 $ (93,916 ) $ 452,045 Cost of goods sold — 158,718 152,355 (92,265 ) 218,808 Gross profit — 110,985 123,903 (1,651 ) 233,237 Selling, general and administrative expenses 8,663 82,844 50,964 (243 ) 142,228 Research and development expenses — 4,894 8,549 — 13,443 Restructuring charges — 591 (11 ) — 580 (Loss) income from continuing operations before interest and taxes (8,663 ) 22,656 64,401 (1,408 ) 76,986 Interest, net 33,358 (18,565 ) 1,260 — 16,053 Loss on extinguishment of debt 10,454 — — — 10,454 (Loss) income from continuing operations before taxes (52,475 ) 41,221 63,141 (1,408 ) 50,479 (Benefit) taxes on (loss) income from continuing operations (17,941 ) 14,917 8,463 (159 ) 5,280 Equity in net income of consolidated subsidiaries 79,246 51,964 122 (131,332 ) — Income from continuing operations 44,712 78,268 54,800 (132,581 ) 45,199 Operating loss from discontinued operations (145 ) — — — (145 ) Taxes on loss from discontinued operations 4 — 41 — 45 Loss from discontinued operations (149 ) — (41 ) — (190 ) Net income 44,563 78,268 54,759 (132,581 ) 45,009 Less: Income from continuing operations attributable to noncontrolling interest — — 446 — 446 Net income attributable to common shareholders 44,563 78,268 54,313 (132,581 ) 44,563 Other comprehensive income attributable to common shareholders 20,986 45,015 24,340 (69,355 ) 20,986 Comprehensive income attributable to common shareholders $ 65,549 $ 123,283 $ 78,653 $ (201,936 ) $ 65,549 Six Months Ended June 26, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 539,341 $ 552,132 $ (193,027 ) $ 898,446 Cost of goods sold — 326,241 279,960 (189,301 ) 416,900 Gross profit — 213,100 272,172 (3,726 ) 481,546 Selling, general and administrative expenses 19,614 167,862 91,356 499 279,331 Research and development expenses 140 15,079 12,606 — 27,825 Restructuring charges — 5,315 4,534 — 9,849 Gain on sale of assets — (378 ) (1,019 ) — (1,397 ) (Loss) income from continuing operations before interest and taxes (19,754 ) 25,222 164,695 (4,225 ) 165,938 Interest, net 66,190 (42,755 ) 2,047 — 25,482 Loss on extinguishment of debt 19,261 — — — 19,261 (Loss) income from continuing operations before taxes (105,205 ) 67,977 162,648 (4,225 ) 121,195 (Benefit) taxes on (loss) income from continuing operations (38,925 ) 26,181 23,773 (409 ) 10,620 Equity in net income of consolidated subsidiaries 176,752 121,505 343 (298,600 ) — Income from continuing operations 110,472 163,301 139,218 (302,416 ) 110,575 Operating (loss) income from discontinued operations (755 ) — 379 — (376 ) (Benefit) taxes on (loss) income from discontinued operations (275 ) — 18 — (257 ) (Loss) income from discontinued operations (480 ) — 361 — (119 ) Net income 109,992 163,301 139,579 (302,416 ) 110,456 Less: Income from continuing operations attributable to noncontrolling interest — — 464 — 464 Net income attributable to common shareholders 109,992 163,301 139,115 (302,416 ) 109,992 Other comprehensive income attributable to common shareholders 14,753 8,888 11,034 (19,922 ) 14,753 Comprehensive income attributable to common shareholders $ 124,745 $ 172,189 $ 150,149 $ (322,338 ) $ 124,745 Six Months Ended June 28, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 533,864 $ 535,159 $ (187,548 ) $ 881,475 Cost of goods sold — 317,044 289,973 (181,416 ) 425,601 Gross profit — 216,820 245,186 (6,132 ) 455,874 Selling, general and administrative expenses 20,115 167,112 94,781 (83 ) 281,925 Research and development expenses — 16,021 10,306 — 26,327 Restructuring charges — 4,330 698 — 5,028 (Loss) income from continuing operations before interest and taxes (20,115 ) 29,357 139,401 (6,049 ) 142,594 Interest, net 67,718 (37,134 ) 2,472 — 33,056 Loss on extinguishment of debt 10,454 — — — 10,454 (Loss) income from continuing operations before taxes (98,287 ) 66,491 136,929 (6,049 ) 99,084 (Benefit) taxes on (loss) income from continuing operations (33,234 ) 25,909 23,207 (1,270 ) 14,612 Equity in net income of consolidated subsidiaries 148,784 111,654 219 (260,657 ) — Income from continuing operations 83,731 152,236 113,941 (265,436 ) 84,472 Operating (loss) income from discontinued operations (648 ) — 4 — (644 ) Taxes on (loss) income from discontinued operations 168 — 81 — 249 Loss from discontinued operations (816 ) — (77 ) — (893 ) Net income 82,915 152,236 113,864 (265,436 ) 83,579 Less: Income from continuing operations attributable to noncontrolling interest — — 664 — 664 Net income attributable to common shareholders 82,915 152,236 113,200 (265,436 ) 82,915 Other comprehensive loss attributable to common shareholders (60,215 ) (61,746 ) (75,388 ) 137,134 (60,215 ) Comprehensive income attributable to common shareholders $ 22,700 $ 90,490 $ 37,812 $ (128,302 ) $ 22,700
Condensed Consolidating Balance Sheets	TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS June 26, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 50,209 $ 1,089 $ 425,192 $ — $ 476,490 Accounts receivable, net 3,139 4,832 261,674 3,885 273,530 Accounts receivable from consolidated subsidiaries 4,914 2,363,862 308,587 (2,677,363 ) — Inventories, net — 203,774 163,045 (28,354 ) 338,465 Prepaid expenses and other current assets 10,289 5,993 15,894 3,665 35,841 Prepaid taxes 8,579 — 21,790 — 30,369 Assets held for sale 2,901 — 4,125 — 7,026 Total current assets 80,031 2,579,550 1,200,307 (2,698,167 ) 1,161,721 Property, plant and equipment, net 2,771 166,228 145,666 — 314,665 Goodwill — 705,754 595,594 — 1,301,348 Intangibles assets, net — 724,239 450,859 — 1,175,098 Investments in affiliates 5,913,792 1,488,669 23,383 (7,425,600 ) 244 Deferred tax assets 86,886 — 6,235 (91,136 ) 1,985 Notes receivable and other amounts due from consolidated subsidiaries 1,353,481 1,786,335 — (3,139,816 ) — Other assets 22,443 6,697 16,006 — 45,146 Total assets $ 7,459,404 $ 7,457,472 $ 2,438,050 $ (13,354,719 ) $ 4,000,207 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 130,652 $ — $ 43,300 $ — $ 173,952 Accounts payable 3,802 34,362 34,623 — 72,787 Accounts payable to consolidated subsidiaries 2,423,041 221,128 33,194 (2,677,363 ) — Accrued expenses 14,963 17,361 31,072 — 63,396 Current portion of contingent consideration — 7,453 — — 7,453 Payroll and benefit-related liabilities 19,447 17,637 33,975 — 71,059 Accrued interest 5,670 — 18 — 5,688 Income taxes payable — — 13,038 (81 ) 12,957 Other current liabilities 4,777 2,157 9,578 — 16,512 Total current liabilities 2,602,352 300,098 198,798 (2,677,444 ) 423,804 Long-term borrowings 907,930 — — — 907,930 Deferred tax liabilities — 372,650 35,813 (91,136 ) 317,327 Pension and other postretirement benefit liabilities 95,719 32,004 16,269 — 143,992 Noncurrent liability for uncertain tax positions 1,503 17,825 7,087 — 26,415 Notes payable and other amounts due to consolidated subsidiaries 1,709,543 1,231,819 198,454 (3,139,816 ) — Other liabilities 23,007 23,505 12,659 — 59,171 Total liabilities 5,340,054 1,977,901 469,080 (5,908,396 ) 1,878,639 Total common shareholders' equity 2,119,350 5,479,571 1,966,752 (7,446,323 ) 2,119,350 Noncontrolling interest — — 2,218 — 2,218 Total equity 2,119,350 5,479,571 1,968,970 (7,446,323 ) 2,121,568 Total liabilities and equity $ 7,459,404 $ 7,457,472 $ 2,438,050 $ (13,354,719 ) $ 4,000,207 December 31, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 21,612 $ — $ 316,754 $ — $ 338,366 Accounts receivable, net 2,538 4,326 251,166 4,386 262,416 Accounts receivable from consolidated subsidiaries 5,276 2,412,079 289,697 (2,707,052 ) — Inventories, net — 205,163 149,705 (24,593 ) 330,275 Prepaid expenses and other current assets 10,511 4,702 16,037 3,665 34,915 Prepaid taxes 16,686 — 14,622 (413 ) 30,895 Assets held for sale 2,901 — 4,071 — 6,972 Total current assets 59,524 2,626,270 1,042,052 (2,724,007 ) 1,003,839 Property, plant and equipment, net 2,931 174,674 138,518 — 316,123 Goodwill — 705,753 590,099 — 1,295,852 Intangibles assets, net — 762,084 437,891 — 1,199,975 Investments in affiliates 5,724,226 1,360,045 23,065 (7,107,184 ) 152 Deferred tax assets 91,432 — 8,042 (97,133 ) 2,341 Notes receivable and other amounts due from consolidated subsidiaries 1,358,446 1,658,092 — (3,016,538 ) — Other assets 22,602 6,615 24,275 — 53,492 Total assets $ 7,259,161 $ 7,293,533 $ 2,263,942 $ (12,944,862 ) $ 3,871,774 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 374,050 $ — $ 43,300 $ — $ 417,350 Accounts payable 1,945 27,527 36,833 — 66,305 Accounts payable to consolidated subsidiaries 2,478,109 201,400 27,543 (2,707,052 ) — Accrued expenses 15,399 22,281 26,337 — 64,017 Current portion of contingent consideration — 7,291 — — 7,291 Payroll and benefit-related liabilities 21,617 29,305 33,736 — 84,658 Accrued interest 7,455 — 25 — 7,480 Income taxes payable — — 8,144 (85 ) 8,059 Other current liabilities 1,300 2,679 4,981 — 8,960 Total current liabilities 2,899,875 290,483 180,899 (2,707,137 ) 664,120 Long-term borrowings 641,850 — — — 641,850 Deferred tax liabilities — 376,738 36,378 (97,133 ) 315,983 Pension and other postretirement benefit liabilities 100,355 32,274 16,812 — 149,441 Noncurrent liability for uncertain tax positions 1,151 17,722 21,527 — 40,400 Notes payable and other amounts due to consolidated subsidiaries 1,585,727 1,253,189 177,622 (3,016,538 ) — Other liabilities 20,931 15,685 12,271 — 48,887 Total liabilities 5,249,889 1,986,091 445,509 (5,820,808 ) 1,860,681 Total common shareholders' equity 2,009,272 5,307,442 1,816,612 (7,124,054 ) 2,009,272 Noncontrolling interest — — 1,821 — 1,821 Total equity 2,009,272 5,307,442 1,818,433 (7,124,054 ) 2,011,093 Total liabilities and equity $ 7,259,161 $ 7,293,533 $ 2,263,942 $ (12,944,862 ) $ 3,871,774
Condensed Consolidating Statements of Cash Flows	TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Six Months Ended June 26, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (29,648 ) $ 69,875 $ 141,261 $ — $ 181,488 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (146 ) (9,947 ) (9,442 ) — (19,535 ) Proceeds from sale of assets — 20,642 1,251 (17,908 ) 3,985 Payments for businesses and intangibles acquired, net of cash acquired — — (21,025 ) 17,908 (3,117 ) Net cash used in investing activities from continuing operations (146 ) 10,695 (29,216 ) — (18,667 ) Cash flows from financing activities of continuing operations: Proceeds from new borrowings 665,000 — — — 665,000 Reduction in borrowings (656,479 ) — — — (656,479 ) Debt extinguishment, issuance and amendment fees (8,182 ) — — — (8,182 ) Net proceeds from share based compensation plans and the related tax impacts 6,593 — — — 6,593 Payments for contingent consideration — (133 ) — — (133 ) Dividends paid (28,998 ) — — — (28,998 ) Intercompany transactions 81,640 (79,348 ) (2,292 ) — — Net cash provided by (used in) financing activities from continuing operations 59,574 (79,481 ) (2,292 ) — (22,199 ) Cash flows from discontinued operations: Net cash used in operating activities (1,183 ) — — — (1,183 ) Net cash used in discontinued operations (1,183 ) — — — (1,183 ) Effect of exchange rate changes on cash and cash equivalents — — (1,315 ) — (1,315 ) Net increase in cash and cash equivalents 28,597 1,089 108,438 — 138,124 Cash and cash equivalents at the beginning of the period 21,612 — 316,754 — 338,366 Cash and cash equivalents at the end of the period $ 50,209 $ 1,089 $ 425,192 $ — $ 476,490 Six Months Ended June 28, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (92,490 ) $ 63,718 $ 140,720 $ (2,360 ) $ 109,588 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (108 ) (17,339 ) (13,874 ) — (31,321 ) Payments for businesses and intangibles acquired, net of cash acquired — (4,348 ) (33,211 ) — (37,559 ) Net cash used in investing activities from continuing operations (108 ) (21,687 ) (47,085 ) — (68,880 ) Cash flows from financing activities of continuing operations: Proceeds from new borrowings 288,100 — — — 288,100 Reduction in borrowings (250,981 ) — — — (250,981 ) Debt extinguishment, issuance and amendment fees (8,746 ) — — — (8,746 ) Net proceeds from share based compensation plans and the related tax impacts 4,843 — — — 4,843 Payments to noncontrolling interest shareholders — — (832 ) — (832 ) Payments for contingent consideration — (3,989 ) — — (3,989 ) Dividends paid (28,234 ) — — — (28,234 ) Intercompany transactions 86,197 (37,744 ) (48,453 ) — — Intercompany dividends paid — — (2,360 ) 2,360 — Net cash provided by (used in) financing activities from continuing operations 91,179 (41,733 ) (51,645 ) 2,360 161 Cash flows from discontinued operations: Net cash used in operating activities (514 ) — (849 ) — (1,363 ) Net cash used in discontinued operations (514 ) — (849 ) — (1,363 ) Effect of exchange rate changes on cash and cash equivalents — — (17,732 ) — (17,732 ) Net (decrease) increase in cash and cash equivalents (1,933 ) 298 23,409 — 21,774 Cash and cash equivalents at the beginning of the period 27,996 — 275,240 — 303,236 Cash and cash equivalents at the end of the period $ 26,063 $ 298 $ 298,649 $ — $ 325,010

Restructuring charges - 2016 Ma

Restructuring charges - 2016 Manufacturing Footprint Realignment Plan (Details) - 2016 Manufacturing footprint realignment plan $ in Millions	3 Months Ended	6 Months Ended
	Jun. 26, 2016USD ($)	Jun. 26, 2016USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	$ 1.8	$ 12.8
Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring expenses		10.4
Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring cost related to accelerated depreciation		2.4
Minimum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	34	34
Restructuring costs expected cash payment	27	27
Minimum | Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	14	14
Minimum | Facility closure and other exit costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	2	2
Minimum | Accelerated Depreciation Charges
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	10	10
Minimum | Other
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	8	8
Maximum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	44	44
Restructuring costs expected cash payment	31	31
Maximum | Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	18	18
Maximum | Facility closure and other exit costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	3	3
Maximum | Accelerated Depreciation Charges
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	13	13
Maximum | Other
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	$ 10	$ 10

Restructuring charges - Additio

Restructuring charges - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ (119)	$ 580	$ 9,849	$ 5,028
2015 Restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(247)	142	(10)	4,380
Aggregate restructuring charges incurred	6,300		6,300
Restructuring reserve	800		800
2014 Manufacturing footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	121	$ 507	(415)	$ 670
Aggregate restructuring charges incurred	10,500		10,500
Restructuring reserve	6,300		6,300
Restructuring expenses	2,400		4,000
2014 Manufacturing footprint realignment plan | Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	100
Restructuring expenses			18,800
Restructuring cost reversal	$ 2,300		4,400
Restructuring charges reversal			$ 400

Restructuring charges - Charges

Restructuring charges - Charges Recognized (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ (119)	$ 580	$ 9,849	$ 5,028
Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(609)	(12)	9,243	3,686
Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	55	267	178	359
Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	115	261	7	901
Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	320	64	421	82
2016 Manufacturing footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	7		10,354
2016 Manufacturing footprint realignment plan | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(279)		10,068
2016 Manufacturing footprint realignment plan | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0		0
2016 Manufacturing footprint realignment plan | Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0		0
2016 Manufacturing footprint realignment plan | Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	286		286
2015 Restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(247)	142	(10)	4,380
2015 Restructuring programs | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(442)	9	(399)	3,559
2015 Restructuring programs | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	55	63	178	129
2015 Restructuring programs | Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	115	24	93	645
2015 Restructuring programs | Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	25	46	118	47
2014 Manufacturing footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	121	507	(415)	670
2014 Manufacturing footprint realignment plan | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	112	75	(426)	212
2014 Manufacturing footprint realignment plan | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	204	0	230
2014 Manufacturing footprint realignment plan | Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	228	0	228
2014 Manufacturing footprint realignment plan | Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 9	0	11	0
Other restructuring programs - prior years
Restructuring Cost and Reserve [Line Items]
Restructuring charges		(69)	(80)	(22)
Other restructuring programs - prior years | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		(96)	0	(85)
Other restructuring programs - prior years | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0	0	0
Other restructuring programs - prior years | Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		9	(86)	28
Other restructuring programs - prior years | Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 18	$ 6	$ 35

Restructuring charges - Charg38

Restructuring charges - Charges by segment (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Restructuring and other impairment charges
Restructuring charges	$ (119)	$ 580	$ 9,849	$ 5,028
Vascular North America
Restructuring and other impairment charges
Restructuring charges	351	520	4,514	2,783
Anesthesia North America
Restructuring and other impairment charges
Restructuring charges	364	(2)	2,239	534
Surgical North America
Restructuring and other impairment charges
Restructuring charges	0	0	(20)	246
EMEA
Restructuring and other impairment charges
Restructuring charges	(949)	(43)	2,923	(75)
Asia
Restructuring and other impairment charges
Restructuring charges	(2)	1	0	1
OEM
Restructuring and other impairment charges
Restructuring charges	(1)	0	4	0
All Other
Restructuring and other impairment charges
Restructuring charges	$ 118	$ 104	$ 189	$ 1,539

Inventories, net (Detail)

Inventories, net (Detail) - USD ($) $ in Thousands	Jun. 26, 2016	Dec. 31, 2015
Inventory Disclosure [Abstract]
Raw materials	$ 79,199	$ 76,037
Work-in-process	57,129	60,218
Finished goods	239,161	230,536
Inventories, gross	375,489	366,791
Less: inventory reserve	(37,024)	(36,516)
Inventories, net	$ 338,465	$ 330,275

Goodwill and other intangible40

Goodwill and other intangible assets, net - Changes in carrying amount of goodwill, by reporting segment (Details) $ in Thousands	6 Months Ended
	Jun. 26, 2016USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 1,295,852
Currency translation adjustment	5,496
Goodwill, ending balance	1,301,348
Operating Segments | Vascular North America
Goodwill [Roll Forward]
Goodwill, beginning balance	345,546
Currency translation adjustment	0
Goodwill, ending balance	345,546
Operating Segments | Anesthesia North America
Goodwill [Roll Forward]
Goodwill, beginning balance	141,122
Currency translation adjustment	405
Goodwill, ending balance	141,527
Operating Segments | Surgical North America
Goodwill [Roll Forward]
Goodwill, beginning balance	250,912
Currency translation adjustment	0
Goodwill, ending balance	250,912
Operating Segments | EMEA
Goodwill [Roll Forward]
Goodwill, beginning balance	306,009
Currency translation adjustment	367
Goodwill, ending balance	306,376
Operating Segments | Asia
Goodwill [Roll Forward]
Goodwill, beginning balance	141,067
Currency translation adjustment	6,864
Goodwill, ending balance	147,931
Operating Segments | OEM
Goodwill [Roll Forward]
Goodwill, beginning balance	1,194
Currency translation adjustment	0
Goodwill, ending balance	1,194
Operating Segments | All Other
Goodwill [Roll Forward]
Goodwill, beginning balance	110,002
Currency translation adjustment	(2,140)
Goodwill, ending balance	$ 107,862

Goodwill and other intangible41

Goodwill and other intangible assets, net - Components of intangible assets (Details) - USD ($) $ in Thousands	Jun. 26, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 1,620,228	$ 1,612,646
Accumulated amortization	(445,130)	(412,671)
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	624,851	621,078
Accumulated amortization	(228,493)	(214,924)
Intellectual property
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	523,189	522,374
Accumulated amortization	(189,454)	(173,903)
Distribution rights
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	23,340	23,279
Accumulated amortization	(15,005)	(14,393)
Trade names
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	387,388	384,821
Accumulated amortization	(11,466)	(8,929)
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	2,846	2,186
Accumulated amortization	(712)	(522)
In-process research and development
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	0	0
Indefinite-lived intangible assets	$ 58,614	$ 58,908

Goodwill and other intangible42

Goodwill and other intangible assets, net - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Amortization expense of intangible assets	$ 16,000	$ 15,100	$ 31,397	$ 29,826
In-process research and development
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	58,614		58,614		$ 58,908
In-process research and development | Semprus Technology
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 41,000		$ 41,000

Borrowings - Components of long

Borrowings - Components of long-term debt (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 26, 2016	May 16, 2016	Dec. 31, 2015	Jun. 28, 2015
Debt Instrument [Line Items]
Total borrowings	$ 1,097,462		$ 1,088,941
Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes due 2017	(4,956)		(22,999)
Less: Unamortized debt issuance costs	(10,624)		(6,742)
Total long-term debt	1,081,882		1,059,200
Current borrowings	(173,952)		(417,350)
Long-term borrowings	907,930		641,850
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility, at a rate of 1.95% at June 26, 2016, due 2018	$ 268,000		396,000
Line of credit facility interest rate	1.95%
Securitization Program
Debt Instrument [Line Items]
Securitization program, at a rate of 1.20% at June 26, 2016	$ 43,300		$ 43,300
Debt instrument, stated interest rate	1.20%		1.18%
5.25% Senior Notes due 2024 | Senior Notes
Debt Instrument [Line Items]
Senior Notes	$ 250,000		$ 250,000
Debt instrument, stated interest rate	5.25%		5.25%
3.875% Convertible Senior Subordinated Notes due 2017 | Senior Notes
Debt Instrument [Line Items]
3.875% Convertible Senior Subordinated Notes due 2017	$ 136,162		$ 399,641
Debt instrument, stated interest rate	3.875%		3.875%	3.875%
4.875% Senior Notes due 2026 | Senior Notes
Debt Instrument [Line Items]
Senior Notes	$ 400,000		$ 0
Debt instrument, stated interest rate	4.875%	4.875%

Borrowings - 4.875% Senior Note

Borrowings - 4.875% Senior Notes (Details) - Senior Notes - 4.875% Senior Notes due 2026 - USD ($)	May 16, 2016	Jun. 26, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Principal amount	$ 400,000,000
Senior Notes		$ 400,000,000	$ 0
Debt instrument, stated interest rate	4.875%	4.875%
Debt issuance cost	$ 6,200,000
Make-whole premium (greater than 1.0% of principal amount), percent		1.00%
Redemption period on or after June 1, 2021
Debt Instrument [Line Items]
Redemption price, percentage		102.438%
Redemption period prior to June 1, 2021
Debt Instrument [Line Items]
Redemption price, percentage		100.00%
Redemption period prior to June 1, 2019
Debt Instrument [Line Items]
Redemption price, percentage		104.875%
Percentage of principal that may be redeemed		40.00%
US Treasury Securities | Redemption period prior to June 1, 2021
Debt Instrument [Line Items]
Basis spread on variable rate		50.00%
Minimum | Redemption period on June 1, 2024
Debt Instrument [Line Items]
Redemption price, percentage		0.813%
Maximum | Redemption period on June 1, 2024
Debt Instrument [Line Items]
Redemption price, percentage		100.00%

Borrowings - 3.875% Convertible

Borrowings - 3.875% Convertible Senior Subordinated Notes (Details) - USD ($) shares in Thousands	Apr. 04, 2016	Apr. 28, 2016	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Short-term Debt [Line Items]
Repayments of debt					$ 656,479,000	$ 250,981,000
Conversion of convertible notes, shares issued upon conversion			1,500	2,700	2,200	2,500
Loss on extinguishment of debt			$ 19,261,000	$ 10,454,000	$ 19,261,000	$ 10,454,000
Exchange Consideration | Convertible Debt | Convertible Notes Payable
Short-term Debt [Line Items]
Extinguishment of debt, amount	$ 219,200,000
Cash payment per $1,000 principal amount	1,000
Repayments of debt	220,700,000
Repayments of debt, accrued interest	$ 1,500,000
Conversion of convertible notes, shares issued upon conversion	2,170
Loss on extinguishment of debt		$ 16,300,000
Hedge Unwind Agreements And Warrant Unwind Agreements | Convertible Debt | Convertible Notes Payable
Short-term Debt [Line Items]
Shares received from dealer counterparties	300

Borrowings - Conversions (Detai

Borrowings - Conversions (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Debt Instrument [Line Items]
Debt conversion, amount converted			$ 35,197	$ 38
Conversion of convertible notes, shares issued upon conversion	1.5	2.7	2.2	2.5
Loss on extinguishment of debt	$ 19,261	$ 10,454	$ 19,261	$ 10,454
Conversion [Member] | Convertible Notes Payable | Convertible Debt
Debt Instrument [Line Items]
Principal amount	$ 44,300		44,300
Debt conversion, amount converted			$ 44,300
Conversion of convertible notes, shares issued upon conversion			0.4
Loss on extinguishment of debt			$ 3,000
Dealer Counterparty | Conversion [Member] | Convertible Notes Payable | Convertible Debt
Debt Instrument [Line Items]
Conversion of convertible notes, shares issued upon conversion			0.4

Borrowings - Repayment of Revol

Borrowings - Repayment of Revolving Credit Facility Borrowings (Details) - USD ($) $ in Thousands	1 Months Ended	6 Months Ended
	Jul. 28, 2016	Jun. 26, 2016	Jun. 28, 2015
Debt Instrument [Line Items]
Repayments of debt		$ 656,479	$ 250,981
Revolving Credit Facility | Subsequent Event
Debt Instrument [Line Items]
Repayments of debt	$ 50,000

Borrowings - Fair value of long

Borrowings - Fair value of long term debt (Details) - USD ($) $ in Thousands	Jun. 26, 2016	Dec. 31, 2015
Fair Value Measurements [Line Items]
Fair value of debt	$ 1,376,433	$ 1,545,781
Level 1
Fair Value Measurements [Line Items]
Fair value of debt	389,423	858,709
Level 2
Fair Value Measurements [Line Items]
Fair value of debt	$ 987,010	$ 687,072

Financial instruments - Additio

Financial instruments - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015	Dec. 31, 2015
Derivatives Fair Value [Line Items]
Allowance for doubtful accounts receivable	$ 8,900,000		$ 8,900,000		$ 8,000,000
Current portion of allowance for doubtful accounts	2,100,000		2,100,000		2,000,000
Noncurrent portion of allowance for doubtful accounts	6,800,000		6,800,000		6,000,000
Net revenues	473,553,000	$ 452,045,000	898,446,000	$ 881,475,000
Spain, Italy, Portugal, and Greece
Derivatives Fair Value [Line Items]
Allowance for doubtful accounts receivable	7,700,000		7,700,000		7,200,000
Net revenues			63,700,000	66,200,000
Net proceeds from share based compensation plans and the related tax impacts
Derivatives Fair Value [Line Items]
Ineffectiveness related to derivatives	0	$ 0	0	$ 0
Designated as Hedging Instrument | Net proceeds from share based compensation plans and the related tax impacts | Foreign Currency Contract
Derivatives Fair Value [Line Items]
Total notional amount for all open foreign currency forward contracts	162,900,000		$ 162,900,000		49,500,000
Derivative duration			9 months
Forward Contracts | Not Designated as Hedging Instrument | Foreign Currency Contract
Derivatives Fair Value [Line Items]
Loss related to currency forward contracts	1,300,000		$ 1,600,000
Total notional amount for all open foreign currency forward contracts	$ 75,600,000		$ 75,600,000		$ 69,100,000

Financial instruments - Fair va

Financial instruments - Fair values of derivative instruments designated as hedging instruments (Details) - Net proceeds from share based compensation plans and the related tax impacts - USD ($) $ in Thousands	Jun. 26, 2016	Dec. 31, 2015
Derivatives Fair Value [Line Items]
Total asset derivatives	$ 1,666	$ 329
Total liability derivatives	4,772	1,298
Forward Contracts | Foreign Currency Contract | Prepaid Expenses and Other Current Assets
Derivatives Fair Value [Line Items]
Total asset derivatives	1,666	329
Forward Contracts | Foreign Currency Contract | Other Current Liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	4,772	1,298
Forward Contracts | Designated as Hedging Instrument | Foreign Currency Contract | Prepaid Expenses and Other Current Assets
Derivatives Fair Value [Line Items]
Total asset derivatives	1,211	285
Forward Contracts | Designated as Hedging Instrument | Foreign Currency Contract | Other Current Liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	3,366	807
Forward Contracts | Not Designated as Hedging Instrument | Foreign Currency Contract | Prepaid Expenses and Other Current Assets
Derivatives Fair Value [Line Items]
Total asset derivatives	455	44
Forward Contracts | Not Designated as Hedging Instrument | Foreign Currency Contract | Other Current Liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	$ 1,406	$ 491

Financial instruments - After t

Financial instruments - After tax (gain)/loss reclassified from accumulated other comprehensive income into income (Details) - Net proceeds from share based compensation plans and the related tax impacts - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives qualifying as hedges, net of tax	$ (496)	$ (803)
Foreign Currency Contract
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives qualifying as hedges, net of tax	$ (496)	$ (803)
Forward Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives qualifying as hedges, net of tax			$ 984	$ (759)
Forward Contracts | Foreign Currency Contract
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives qualifying as hedges, net of tax			$ 984	$ (759)

Financial instruments - Aggrega

Financial instruments - Aggregate accounts receivable, net of allowance for doubtful accounts (Details) - USD ($) $ in Thousands	Jun. 26, 2016	Dec. 31, 2015
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for doubtful accounts receivable	$ 8,900	$ 8,000
Spain, Italy, Portugal, and Greece
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for doubtful accounts receivable	7,700	7,200
Current and long-term accounts receivable (net of allowances of $7.7 million and $7.2 million at June 26, 2016 and December 31, 2015, respectively) in Greece, Italy, Spain and Portugal (1)	$ 65,638	$ 62,272
Percentage of total net current and long-term accounts receivable - Greece, Italy, Spain and Portugal	23.40%	23.90%
Long-term portion of accounts receivable, net	$ 9,600	$ 8,100

Fair value measurement - Additi

Fair value measurement - Additional Information (Detail) - USD ($) $ in Thousands	Jun. 26, 2016	Dec. 31, 2015
Fair Value Measurements [Line Items]
Fair value measurement with unobservable inputs reconciliations liability value	$ 21,938	$ 20,829
Current portion of contingent consideration	7,453	$ 7,291
Fair value measurement with unobservable inputs reconciliations other liabilities	14,400
Minimum
Fair Value Measurements [Line Items]
Fair value of contingent consideration liability associated with future milestone	7,000
Maximum
Fair Value Measurements [Line Items]
Fair value of contingent consideration liability associated with future milestone	$ 46,400

Fair value measurement - Financ

Fair value measurement - Financial assets and liabilities carried at fair value measured on recurring basis (Details) - USD ($) $ in Thousands	Jun. 26, 2016	Dec. 31, 2015
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	$ 7,163	$ 6,922
Derivative assets	1,666	329
Derivative liabilities	4,772	1,298
Contingent consideration liabilities	21,938	20,829
Quoted prices in active markets (Level 1)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	7,163	6,922
Derivative assets	0	0
Derivative liabilities	0	0
Contingent consideration liabilities	0	0
Significant other observable Inputs (Level 2)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	0	0
Derivative assets	1,666	329
Derivative liabilities	4,772	1,298
Contingent consideration liabilities	0	0
Significant unobservable Inputs (Level 3)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	0	0
Derivative assets	0	0
Derivative liabilities	0	0
Contingent consideration liabilities	$ 21,938	$ 20,829

Fair value measurement - Reconc

Fair value measurement - Reconciliation of changes in financial liabilities measured on recurring basis (Details) $ in Thousands	6 Months Ended
	Jun. 26, 2016USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 20,829
Payment	(133)
Revaluations	1,242
Ending balance	$ 21,938

Fair value measurement - Valuat

Fair value measurement - Valuation technique and inputs used to determine fair value (Details)	6 Months Ended
	Jun. 26, 2016
Probability Of Payment | Weighted Average
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	71.30%
Probability Of Payment | Minimum
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	2.00%
Probability Of Payment | Maximum
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	100.00%
Market Approach Valuation Technique | Weighted Average
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	8.40%
Market Approach Valuation Technique | Minimum
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	2.60%
Market Approach Valuation Technique | Maximum
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	10.00%

Changes in shareholders' equi57

Changes in shareholders' equity - Additional Information (Details) - $ / shares shares in Millions	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Shareholders Equity [Line Items]
Investment warrants, exercise price			$ 74.65
Conversion of convertible notes, shares issued upon conversion	1.5	2.7	2.2	2.5
Equity Option
Shareholders Equity [Line Items]
Weighted average antidilutive shares which were not included in the calculation of earnings per share	5	5.6	5.1	5.7
Convertible Note
Shareholders Equity [Line Items]
Weighted average antidilutive shares which were not included in the calculation of earnings per share	1.7	3.3	2.6	3.2

Changes in shareholders' equi58

Changes in shareholders' equity - Reconciliation of basic to diluted weighted average common shares outstanding (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015	Dec. 31, 2015
Debt Instrument [Line Items]
Basic (in shares)	43,549	41,560	42,598	41,514
Dilutive effect of share-based awards (in shares)	566	473	543	470
Dilutive effect of 3.875% Convertible Notes and warrants (in shares)	3,131	6,048	4,873	5,704
Diluted (in shares)	47,246	48,081	48,014	47,688
Senior Notes | 3.875% Convertible Senior Subordinated Notes due 2017
Debt Instrument [Line Items]
Debt instrument, stated interest rate	3.875%	3.875%	3.875%	3.875%	3.875%

Changes in shareholders' equi59

Changes in shareholders' equity - Change in accumulated other comprehensive income, net of tax (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance			$ 2,011,093
Amounts reclassified from accumulated other comprehensive income	$ 2,191	$ 1,403	4,777	$ 2,300
Ending Balance	2,121,568		2,121,568
Cash Flow Hedges
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance			(2,491)	0
Other comprehensive income (loss) before reclassifications			(1,684)	(922)
Amounts reclassified from accumulated other comprehensive income			2,668	163
Net current-period other comprehensive income			984	(759)
Ending Balance	(1,507)	(759)	(1,507)	(759)
Pension and Other Postretirement Benefit Plans
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance			(138,887)	(141,744)
Other comprehensive income (loss) before reclassifications			375	300
Amounts reclassified from accumulated other comprehensive income			2,109	2,137
Net current-period other comprehensive income			2,484	2,437
Ending Balance	(136,403)	(139,307)	(136,403)	(139,307)
Foreign Currency Translation Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance			(229,746)	(119,151)
Other comprehensive income (loss) before reclassifications			11,285	(61,893)
Amounts reclassified from accumulated other comprehensive income			0	0
Net current-period other comprehensive income			11,285	(61,893)
Ending Balance	(218,461)	(181,044)	(218,461)	(181,044)
Accumulated Other Comprehensive (Loss) Income
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance			(371,124)	(260,895)
Other comprehensive income (loss) before reclassifications			9,976	(62,515)
Amounts reclassified from accumulated other comprehensive income			4,777	2,300
Net current-period other comprehensive income			14,753	(60,215)
Ending Balance	$ (356,371)	$ (321,110)	$ (356,371)	$ (321,110)

Changes in shareholders' equi60

Changes in shareholders' equity - Accumulated other comprehensive income into income expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cost of goods sold	$ (217,154)	$ (218,808)	$ (416,900)	$ (425,601)
Total reclassifications, net of tax	2,191	1,403	4,777	2,300
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	1,501	472	3,372	263
Tax (benefit) expense	(363)	(110)	(704)	(100)
Total reclassifications, net of tax	1,138	362	2,668	163
Pension and Other Postretirement Benefits Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	1,634	1,605	3,270	3,211
Tax (benefit) expense	(581)	(564)	(1,161)	(1,074)
Total reclassifications, net of tax	1,053	1,041	2,109	2,137
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	1,620	1,605	3,242	3,211
Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	14	0	28	0
Foreign Currency Contract | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cost of goods sold	$ 1,501	$ 472	$ 3,372	$ 263

Taxes on income from continui61

Taxes on income from continuing operations - Additional Information (Details)	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Income Tax Disclosure [Abstract]
Effective income tax rate	11.90%	10.50%	8.80%	14.70%

Pension and other postretirem62

Pension and other postretirement benefits (Detail) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 26, 2016	Jun. 26, 2016
Compensation and Retirement Disclosure [Abstract]
Expected employer contribution for current year		$ 2.4
Employer contribution to pension plan	$ 1.7

Pension and other postretirem63

Pension and other postretirement benefits - Net benefit cost of pension and postretirement benefit plans (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Pension
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 655	$ 469	$ 1,307	$ 940
Interest cost	3,929	4,485	7,849	8,971
Expected return on plan assets	(6,199)	(6,427)	(12,397)	(12,852)
Net amortization and deferral	1,577	1,528	3,156	3,058
Net benefits expense (income)	(38)	55	(85)	117
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	111	107	222	214
Interest cost	407	511	813	1,023
Expected return on plan assets	0	0	0	0
Net amortization and deferral	57	78	114	155
Net benefits expense (income)	$ 575	$ 696	$ 1,149	$ 1,392

Commitments and contingent li64

Commitments and contingent liabilities (Detail) - USD ($)	Dec. 05, 2014	Jun. 26, 2016
Loss Contingencies [Line Items]
Estimated litigation liability		$ 2,600,000
Parish of Calcasieu | Judicial Ruling | Compensatory Damages
Loss Contingencies [Line Items]
Damages awarded	$ 100,000
Parish of Calcasieu | Judicial Ruling | Punitive Damages
Loss Contingencies [Line Items]
Damages awarded	$ 23,000,000
Parish of Calcasieu | Judicial Ruling | Unfavorable Regulatory Action
Loss Contingencies [Line Items]
Possible loss		10,000,000
Discontinued Operations
Loss Contingencies [Line Items]
Estimated litigation liability		$ 1,500,000
Minimum
Loss Contingencies [Line Items]
Time-frame over which the accrued amounts may be paid out, in years		15 years
Maximum
Loss Contingencies [Line Items]
Time-frame over which the accrued amounts may be paid out, in years		20 years
Accrued Liabilities
Loss Contingencies [Line Items]
Waste disposed accrued liability		$ 1,100,000
Other Liability
Loss Contingencies [Line Items]
Waste disposed accrued liability		6,000,000
Construction In Progress | European Headquarters
Loss Contingencies [Line Items]
Estimated cost		16,400,000
Property, plant and equipment		$ 8,400,000

Segment information (Details)

Segment information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016USD ($)	Jun. 28, 2015USD ($)	Jun. 26, 2016USD ($)segmentmarket	Jun. 28, 2015USD ($)
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of reportable operating segments | segment			6
Number of end markets | market			2,000
Revenue	$ 473,553	$ 452,045	$ 898,446	$ 881,475
Operating profit	98,441	76,986	165,938	142,594
Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit	111,738	96,319	201,810	179,973
Unallocated expenses
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit	(13,297)	(19,333)	(35,872)	(37,379)
Vascular North America | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	88,111	81,165	169,699	161,931
Operating profit	21,994	17,055	41,650	32,805
Anesthesia North America | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	49,194	45,579	95,151	91,028
Operating profit	15,050	11,434	27,227	21,394
Surgical North America | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	43,136	40,520	82,077	78,579
Operating profit	12,348	14,315	25,604	26,642
EMEA | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	131,705	129,132	253,800	258,414
Operating profit	23,944	19,343	44,987	45,678
Asia | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	63,191	62,042	112,347	110,571
Operating profit	21,751	18,951	34,759	27,097
OEM | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	40,298	37,918	74,275	72,633
Operating profit	9,215	8,366	14,404	16,409
All other | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	57,918	55,689	111,097	108,319
Operating profit	$ 7,436	$ 6,855	$ 13,179	$ 9,948

Condensed consolidating guara66

Condensed consolidating guarantor financial information - Additional Information (Detail)	Jun. 26, 2016	Dec. 31, 2015
Condensed Financial Statements Captions [Line Items]
Ownership percentage of subsidiaries	100.00%
Senior Notes | 5.25% Senior Notes due 2024
Condensed Financial Statements Captions [Line Items]
Debt instrument, stated interest rate	5.25%	5.25%

Condensed consolidating guara67

Condensed consolidating guarantor financial information - Income and Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015	Jun. 26, 2016	Jun. 28, 2015
Condensed Income Statements, Captions [Line Items]
Net revenues	$ 473,553	$ 452,045	$ 898,446	$ 881,475
Cost of goods sold	217,154	218,808	416,900	425,601
Gross profit	256,399	233,237	481,546	455,874
Selling, general and administrative expenses	142,983	142,228	279,331	281,925
Research and development expenses	15,472	13,443	27,825	26,327
Restructuring charges	(119)	580	9,849	5,028
Gain on sale of assets	(378)	0	(1,397)	0
Income from continuing operations before interest and taxes	98,441	76,986	165,938	142,594
Interest, net	11,778	16,053	25,482	33,056
Loss on extinguishment of debt	19,261	10,454	19,261	10,454
Income from continuing operations before taxes	67,402	50,479	121,195	99,084
(Benefit) taxes on (loss) income from continuing operations	8,007	5,280	10,620	14,612
Equity in net income of consolidated subsidiaries	0	0	0	0
Income from continuing operations	59,395	45,199	110,575	84,472
Operating (loss) income from discontinued operations	6	(145)	(376)	(644)
Tax (benefit) on (loss) income from discontinued operations	(187)	45	(257)	249
Income (loss) from discontinued operations	193	(190)	(119)	(893)
Net income	59,588	45,009	110,456	83,579
Less: Income from continuing operations attributable to noncontrolling interest	285	446	464	664
Net income attributable to common shareholders	59,303	44,563	109,992	82,915
Other comprehensive loss attributable to common shareholders	(8,441)	20,986	14,753	(60,215)
Comprehensive income attributable to common shareholders	50,862	65,549	124,745	22,700
Consolidation, Eliminations
Condensed Income Statements, Captions [Line Items]
Net revenues	(97,661)	(93,916)	(193,027)	(187,548)
Cost of goods sold	(100,543)	(92,265)	(189,301)	(181,416)
Gross profit	2,882	(1,651)	(3,726)	(6,132)
Selling, general and administrative expenses	16	(243)	499	(83)
Research and development expenses	0	0	0	0
Restructuring charges	0	0	0	0
Gain on sale of assets	0		0
Income from continuing operations before interest and taxes	2,866	(1,408)	(4,225)	(6,049)
Interest, net	0	0	0	0
Loss on extinguishment of debt	0	0	0	0
Income from continuing operations before taxes	2,866	(1,408)	(4,225)	(6,049)
(Benefit) taxes on (loss) income from continuing operations	671	(159)	(409)	(1,270)
Equity in net income of consolidated subsidiaries	(163,075)	(131,332)	(298,600)	(260,657)
Income from continuing operations	(160,880)	(132,581)	(302,416)	(265,436)
Operating (loss) income from discontinued operations	0	0	0	0
Tax (benefit) on (loss) income from discontinued operations	0	0	0	0
Income (loss) from discontinued operations	0	0	0	0
Net income	(160,880)	(132,581)	(302,416)	(265,436)
Less: Income from continuing operations attributable to noncontrolling interest	0	0	0	0
Net income attributable to common shareholders	(160,880)	(132,581)	(302,416)	(265,436)
Other comprehensive loss attributable to common shareholders	21,063	(69,355)	(19,922)	137,134
Comprehensive income attributable to common shareholders	(139,817)	(201,936)	(322,338)	(128,302)
Parent Company | Reportable Legal Entities
Condensed Income Statements, Captions [Line Items]
Net revenues	0	0	0	0
Cost of goods sold	0	0	0	0
Gross profit	0	0	0	0
Selling, general and administrative expenses	10,285	8,663	19,614	20,115
Research and development expenses	140	0	140	0
Restructuring charges	0	0	0	0
Gain on sale of assets	0		0
Income from continuing operations before interest and taxes	(10,425)	(8,663)	(19,754)	(20,115)
Interest, net	33,146	33,358	66,190	67,718
Loss on extinguishment of debt	19,261	10,454	19,261	10,454
Income from continuing operations before taxes	(62,832)	(52,475)	(105,205)	(98,287)
(Benefit) taxes on (loss) income from continuing operations	(23,077)	(17,941)	(38,925)	(33,234)
Equity in net income of consolidated subsidiaries	99,295	79,246	176,752	148,784
Income from continuing operations	59,540	44,712	110,472	83,731
Operating (loss) income from discontinued operations	(373)	(145)	(755)	(648)
Tax (benefit) on (loss) income from discontinued operations	(136)	4	(275)	168
Income (loss) from discontinued operations	(237)	(149)	(480)	(816)
Net income	59,303	44,563	109,992	82,915
Less: Income from continuing operations attributable to noncontrolling interest	0	0	0	0
Net income attributable to common shareholders	59,303	44,563	109,992	82,915
Other comprehensive loss attributable to common shareholders	(8,441)	20,986	14,753	(60,215)
Comprehensive income attributable to common shareholders	50,862	65,549	124,745	22,700
Guarantor Subsidiaries | Reportable Legal Entities
Condensed Income Statements, Captions [Line Items]
Net revenues	280,430	269,703	539,341	533,864
Cost of goods sold	170,700	158,718	326,241	317,044
Gross profit	109,730	110,985	213,100	216,820
Selling, general and administrative expenses	86,385	82,844	167,862	167,112
Research and development expenses	8,644	4,894	15,079	16,021
Restructuring charges	557	591	5,315	4,330
Gain on sale of assets	(378)		(378)
Income from continuing operations before interest and taxes	14,522	22,656	25,222	29,357
Interest, net	(22,437)	(18,565)	(42,755)	(37,134)
Loss on extinguishment of debt	0	0	0	0
Income from continuing operations before taxes	36,959	41,221	67,977	66,491
(Benefit) taxes on (loss) income from continuing operations	14,504	14,917	26,181	25,909
Equity in net income of consolidated subsidiaries	63,605	51,964	121,505	111,654
Income from continuing operations	86,060	78,268	163,301	152,236
Operating (loss) income from discontinued operations	0	0	0	0
Tax (benefit) on (loss) income from discontinued operations	0	0	0	0
Income (loss) from discontinued operations	0	0	0	0
Net income	86,060	78,268	163,301	152,236
Less: Income from continuing operations attributable to noncontrolling interest	0	0	0	0
Net income attributable to common shareholders	86,060	78,268	163,301	152,236
Other comprehensive loss attributable to common shareholders	(9,685)	45,015	8,888	(61,746)
Comprehensive income attributable to common shareholders	76,375	123,283	172,189	90,490
Non-Guarantor Subsidiaries | Reportable Legal Entities
Condensed Income Statements, Captions [Line Items]
Net revenues	290,784	276,258	552,132	535,159
Cost of goods sold	146,997	152,355	279,960	289,973
Gross profit	143,787	123,903	272,172	245,186
Selling, general and administrative expenses	46,297	50,964	91,356	94,781
Research and development expenses	6,688	8,549	12,606	10,306
Restructuring charges	(676)	(11)	4,534	698
Gain on sale of assets	0		(1,019)
Income from continuing operations before interest and taxes	91,478	64,401	164,695	139,401
Interest, net	1,069	1,260	2,047	2,472
Loss on extinguishment of debt	0	0	0	0
Income from continuing operations before taxes	90,409	63,141	162,648	136,929
(Benefit) taxes on (loss) income from continuing operations	15,909	8,463	23,773	23,207
Equity in net income of consolidated subsidiaries	175	122	343	219
Income from continuing operations	74,675	54,800	139,218	113,941
Operating (loss) income from discontinued operations	379	0	379	4
Tax (benefit) on (loss) income from discontinued operations	(51)	41	18	81
Income (loss) from discontinued operations	430	(41)	361	(77)
Net income	75,105	54,759	139,579	113,864
Less: Income from continuing operations attributable to noncontrolling interest	285	446	464	664
Net income attributable to common shareholders	74,820	54,313	139,115	113,200
Other comprehensive loss attributable to common shareholders	(11,378)	24,340	11,034	(75,388)
Comprehensive income attributable to common shareholders	$ 63,442	$ 78,653	$ 150,149	$ 37,812

Condensed consolidating guara68

Condensed consolidating guarantor financial information - Balance Sheets (Details) - USD ($) $ in Thousands	Jun. 26, 2016	Dec. 31, 2015	Jun. 28, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 476,490	$ 338,366	$ 325,010	$ 303,236
Accounts receivable, net	273,530	262,416
Accounts receivable from consolidated subsidiaries	0	0
Inventories, net	338,465	330,275
Prepaid expenses and other current assets	35,841	34,915
Prepaid taxes	30,369	30,895
Assets held for sale	7,026	6,972
Total current assets	1,161,721	1,003,839
Property, plant and equipment, net	314,665	316,123
Goodwill	1,301,348	1,295,852
Intangible assets, net	1,175,098	1,199,975
Investments in affiliates	244	152
Deferred tax assets	1,985	2,341
Notes receivable and other amounts due from consolidated subsidiaries	0	0
Other assets	45,146	53,492
Total assets	4,000,207	3,871,774
Current liabilities
Current borrowings	173,952	417,350
Accounts payable	72,787	66,305
Accounts payable to consolidated subsidiaries	0	0
Accrued expenses	63,396	64,017
Current portion of contingent consideration	7,453	7,291
Payroll and benefit-related liabilities	71,059	84,658
Accrued interest	5,688	7,480
Income taxes payable	12,957	8,059
Other current liabilities	16,512	8,960
Total current liabilities	423,804	664,120
Long-term borrowings	907,930	641,850
Deferred tax liabilities	317,327	315,983
Pension and other postretirement benefit liabilities	143,992	149,441
Noncurrent liability for uncertain tax positions	26,415	40,400
Notes payable and other amounts due to consolidated subsidiaries	0	0
Other liabilities	59,171	48,887
Total liabilities	1,878,639	1,860,681
Total common shareholders' equity	2,119,350	2,009,272
Noncontrolling interest	2,218	1,821
Total equity	2,121,568	2,011,093
Total liabilities and equity	4,000,207	3,871,774
Consolidation, Eliminations
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	3,885	4,386
Accounts receivable from consolidated subsidiaries	(2,677,363)	(2,707,052)
Inventories, net	(28,354)	(24,593)
Prepaid expenses and other current assets	3,665	3,665
Prepaid taxes	0	(413)
Assets held for sale	0	0
Total current assets	(2,698,167)	(2,724,007)
Property, plant and equipment, net	0	0
Goodwill	0	0
Intangible assets, net	0	0
Investments in affiliates	(7,425,600)	(7,107,184)
Deferred tax assets	(91,136)	(97,133)
Notes receivable and other amounts due from consolidated subsidiaries	(3,139,816)	(3,016,538)
Other assets	0	0
Total assets	(13,354,719)	(12,944,862)
Current liabilities
Current borrowings	0	0
Accounts payable	0	0
Accounts payable to consolidated subsidiaries	(2,677,363)	(2,707,052)
Accrued expenses	0	0
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	0	0
Accrued interest	0	0
Income taxes payable	(81)	(85)
Other current liabilities	0	0
Total current liabilities	(2,677,444)	(2,707,137)
Long-term borrowings	0	0
Deferred tax liabilities	(91,136)	(97,133)
Pension and other postretirement benefit liabilities	0	0
Noncurrent liability for uncertain tax positions	0	0
Notes payable and other amounts due to consolidated subsidiaries	(3,139,816)	(3,016,538)
Other liabilities	0	0
Total liabilities	(5,908,396)	(5,820,808)
Total common shareholders' equity	(7,446,323)	(7,124,054)
Noncontrolling interest	0	0
Total equity	(7,446,323)	(7,124,054)
Total liabilities and equity	(13,354,719)	(12,944,862)
Parent Company | Reportable Legal Entities
Current assets
Cash and cash equivalents	50,209	21,612	26,063	27,996
Accounts receivable, net	3,139	2,538
Accounts receivable from consolidated subsidiaries	4,914	5,276
Inventories, net	0	0
Prepaid expenses and other current assets	10,289	10,511
Prepaid taxes	8,579	16,686
Assets held for sale	2,901	2,901
Total current assets	80,031	59,524
Property, plant and equipment, net	2,771	2,931
Goodwill	0	0
Intangible assets, net	0	0
Investments in affiliates	5,913,792	5,724,226
Deferred tax assets	86,886	91,432
Notes receivable and other amounts due from consolidated subsidiaries	1,353,481	1,358,446
Other assets	22,443	22,602
Total assets	7,459,404	7,259,161
Current liabilities
Current borrowings	130,652	374,050
Accounts payable	3,802	1,945
Accounts payable to consolidated subsidiaries	2,423,041	2,478,109
Accrued expenses	14,963	15,399
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	19,447	21,617
Accrued interest	5,670	7,455
Income taxes payable	0	0
Other current liabilities	4,777	1,300
Total current liabilities	2,602,352	2,899,875
Long-term borrowings	907,930	641,850
Deferred tax liabilities	0	0
Pension and other postretirement benefit liabilities	95,719	100,355
Noncurrent liability for uncertain tax positions	1,503	1,151
Notes payable and other amounts due to consolidated subsidiaries	1,709,543	1,585,727
Other liabilities	23,007	20,931
Total liabilities	5,340,054	5,249,889
Total common shareholders' equity	2,119,350	2,009,272
Noncontrolling interest	0	0
Total equity	2,119,350	2,009,272
Total liabilities and equity	7,459,404	7,259,161
Guarantor Subsidiaries | Reportable Legal Entities
Current assets
Cash and cash equivalents	1,089	0	298	0
Accounts receivable, net	4,832	4,326
Accounts receivable from consolidated subsidiaries	2,363,862	2,412,079
Inventories, net	203,774	205,163
Prepaid expenses and other current assets	5,993	4,702
Prepaid taxes	0	0
Assets held for sale	0	0
Total current assets	2,579,550	2,626,270
Property, plant and equipment, net	166,228	174,674
Goodwill	705,754	705,753
Intangible assets, net	724,239	762,084
Investments in affiliates	1,488,669	1,360,045
Deferred tax assets	0	0
Notes receivable and other amounts due from consolidated subsidiaries	1,786,335	1,658,092
Other assets	6,697	6,615
Total assets	7,457,472	7,293,533
Current liabilities
Current borrowings	0	0
Accounts payable	34,362	27,527
Accounts payable to consolidated subsidiaries	221,128	201,400
Accrued expenses	17,361	22,281
Current portion of contingent consideration	7,453	7,291
Payroll and benefit-related liabilities	17,637	29,305
Accrued interest	0	0
Income taxes payable	0	0
Other current liabilities	2,157	2,679
Total current liabilities	300,098	290,483
Long-term borrowings	0	0
Deferred tax liabilities	372,650	376,738
Pension and other postretirement benefit liabilities	32,004	32,274
Noncurrent liability for uncertain tax positions	17,825	17,722
Notes payable and other amounts due to consolidated subsidiaries	1,231,819	1,253,189
Other liabilities	23,505	15,685
Total liabilities	1,977,901	1,986,091
Total common shareholders' equity	5,479,571	5,307,442
Noncontrolling interest	0	0
Total equity	5,479,571	5,307,442
Total liabilities and equity	7,457,472	7,293,533
Non-Guarantor Subsidiaries | Reportable Legal Entities
Current assets
Cash and cash equivalents	425,192	316,754	$ 298,649	$ 275,240
Accounts receivable, net	261,674	251,166
Accounts receivable from consolidated subsidiaries	308,587	289,697
Inventories, net	163,045	149,705
Prepaid expenses and other current assets	15,894	16,037
Prepaid taxes	21,790	14,622
Assets held for sale	4,125	4,071
Total current assets	1,200,307	1,042,052
Property, plant and equipment, net	145,666	138,518
Goodwill	595,594	590,099
Intangible assets, net	450,859	437,891
Investments in affiliates	23,383	23,065
Deferred tax assets	6,235	8,042
Notes receivable and other amounts due from consolidated subsidiaries	0	0
Other assets	16,006	24,275
Total assets	2,438,050	2,263,942
Current liabilities
Current borrowings	43,300	43,300
Accounts payable	34,623	36,833
Accounts payable to consolidated subsidiaries	33,194	27,543
Accrued expenses	31,072	26,337
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	33,975	33,736
Accrued interest	18	25
Income taxes payable	13,038	8,144
Other current liabilities	9,578	4,981
Total current liabilities	198,798	180,899
Long-term borrowings	0	0
Deferred tax liabilities	35,813	36,378
Pension and other postretirement benefit liabilities	16,269	16,812
Noncurrent liability for uncertain tax positions	7,087	21,527
Notes payable and other amounts due to consolidated subsidiaries	198,454	177,622
Other liabilities	12,659	12,271
Total liabilities	469,080	445,509
Total common shareholders' equity	1,966,752	1,816,612
Noncontrolling interest	2,218	1,821
Total equity	1,968,970	1,818,433
Total liabilities and equity	$ 2,438,050	$ 2,263,942

Condensed consolidating guara69

Condensed consolidating guarantor financial information - Cash Flows (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 26, 2016	Jun. 28, 2015
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net cash (used in) provided by operating activities from continuing operations	$ 181,488	$ 109,588
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(19,535)	(31,321)
Proceeds from sale of assets	3,985	0
Payments for businesses and intangibles acquired, net of cash acquired	(3,117)	(37,559)
Net cash used in investing activities from continuing operations	(18,667)	(68,880)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings	665,000	288,100
Reduction in borrowings	(656,479)	(250,981)
Debt extinguishment, issuance and amendment fees	(8,182)	(8,746)
Net proceeds from share based compensation plans and the related tax impacts	6,593	4,843
Payments to noncontrolling interest shareholders	0	(832)
Payments for contingent consideration	(133)	(3,989)
Dividends paid	(28,998)	(28,234)
Intercompany transactions	0	0
Intercompany dividends paid		0
Net cash (used in) provided by financing activities from continuing operations	(22,199)	161
Cash flows from discontinued operations:
Net cash used in operating activities	(1,183)	(1,363)
Net cash used in discontinued operations	(1,183)	(1,363)
Effect of exchange rate changes on cash and cash equivalents	(1,315)	(17,732)
Net increase in cash and cash equivalents	138,124	21,774
Cash and cash equivalents at the beginning of the period	338,366	303,236
Cash and cash equivalents at the end of the period	476,490	325,010
Consolidation, Eliminations
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net cash (used in) provided by operating activities from continuing operations	0	(2,360)
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	0	0
Proceeds from sale of assets	(17,908)
Payments for businesses and intangibles acquired, net of cash acquired	17,908	0
Net cash used in investing activities from continuing operations	0	0
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings	0	0
Reduction in borrowings	0	0
Debt extinguishment, issuance and amendment fees	0	0
Net proceeds from share based compensation plans and the related tax impacts	0	0
Payments to noncontrolling interest shareholders		0
Payments for contingent consideration	0	0
Dividends paid	0	0
Intercompany transactions	0	0
Intercompany dividends paid		2,360
Net cash (used in) provided by financing activities from continuing operations	0	2,360
Cash flows from discontinued operations:
Net cash used in operating activities	0	0
Net cash used in discontinued operations	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase in cash and cash equivalents	0	0
Cash and cash equivalents at the beginning of the period	0	0
Cash and cash equivalents at the end of the period	0	0
Parent Company | Reportable Legal Entities
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net cash (used in) provided by operating activities from continuing operations	(29,648)	(92,490)
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(146)	(108)
Proceeds from sale of assets	0
Payments for businesses and intangibles acquired, net of cash acquired	0	0
Net cash used in investing activities from continuing operations	(146)	(108)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings	665,000	288,100
Reduction in borrowings	(656,479)	(250,981)
Debt extinguishment, issuance and amendment fees	(8,182)	(8,746)
Net proceeds from share based compensation plans and the related tax impacts	6,593	4,843
Payments to noncontrolling interest shareholders		0
Payments for contingent consideration	0	0
Dividends paid	(28,998)	(28,234)
Intercompany transactions	81,640	86,197
Intercompany dividends paid		0
Net cash (used in) provided by financing activities from continuing operations	59,574	91,179
Cash flows from discontinued operations:
Net cash used in operating activities	(1,183)	(514)
Net cash used in discontinued operations	(1,183)	(514)
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase in cash and cash equivalents	28,597	(1,933)
Cash and cash equivalents at the beginning of the period	21,612	27,996
Cash and cash equivalents at the end of the period	50,209	26,063
Guarantor Subsidiaries | Reportable Legal Entities
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net cash (used in) provided by operating activities from continuing operations	69,875	63,718
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(9,947)	(17,339)
Proceeds from sale of assets	20,642
Payments for businesses and intangibles acquired, net of cash acquired	0	(4,348)
Net cash used in investing activities from continuing operations	10,695	(21,687)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings	0	0
Reduction in borrowings	0	0
Debt extinguishment, issuance and amendment fees	0	0
Net proceeds from share based compensation plans and the related tax impacts	0	0
Payments to noncontrolling interest shareholders		0
Payments for contingent consideration	(133)	(3,989)
Dividends paid	0	0
Intercompany transactions	(79,348)	(37,744)
Intercompany dividends paid		0
Net cash (used in) provided by financing activities from continuing operations	(79,481)	(41,733)
Cash flows from discontinued operations:
Net cash used in operating activities	0	0
Net cash used in discontinued operations	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase in cash and cash equivalents	1,089	298
Cash and cash equivalents at the beginning of the period	0	0
Cash and cash equivalents at the end of the period	1,089	298
Non-Guarantor Subsidiaries | Reportable Legal Entities
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net cash (used in) provided by operating activities from continuing operations	141,261	140,720
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(9,442)	(13,874)
Proceeds from sale of assets	1,251
Payments for businesses and intangibles acquired, net of cash acquired	(21,025)	(33,211)
Net cash used in investing activities from continuing operations	(29,216)	(47,085)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings	0	0
Reduction in borrowings	0	0
Debt extinguishment, issuance and amendment fees	0	0
Net proceeds from share based compensation plans and the related tax impacts	0	0
Payments to noncontrolling interest shareholders		(832)
Payments for contingent consideration	0	0
Dividends paid	0	0
Intercompany transactions	(2,292)	(48,453)
Intercompany dividends paid		(2,360)
Net cash (used in) provided by financing activities from continuing operations	(2,292)	(51,645)
Cash flows from discontinued operations:
Net cash used in operating activities	0	(849)
Net cash used in discontinued operations	0	(849)
Effect of exchange rate changes on cash and cash equivalents	(1,315)	(17,732)
Net increase in cash and cash equivalents	108,438	23,409
Cash and cash equivalents at the beginning of the period	316,754	275,240
Cash and cash equivalents at the end of the period	$ 425,192	$ 298,649